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Summary 
 
Emerging evidence supports a role for microRNAs (miRNAs) in the regulation 
of synaptic plasticity and memory formation. We investigated if protein 
phosphatase 1 (PP1), a potent memory suppressor, can modulate the 
expression of miRNAs relevant for memory, and whether a dysregulation of 
PP1-dependent miRNAs is implicated in age-related cognitive decline (ARCD).   
 
For this, we conducted deep-sequencing screenings for hippocampal miRNAs 
that are differentially regulated during memory formation, as well as, those 
from a transgenic mouse model of improved memory resulting from inhibition 
of nuclear PP1 (NIPP1*) in forebrain neurons. Specific miRNAs, notably 
miRNA cluster miR-183/96/182, were differentially expressed in the 
hippocampus of NIPP1* mice. The cluster showed a similar pattern of 
regulation in wild-type mice after training. Importantly, over-expression of the 
cluster in the adult mouse hippocampus enhanced long-term memory, 
whereas, its inhibition impaired memory. Mechanistic in vitro studies show that 
PP1 regulates the biogenesis of miR-183/96/182 in a transcription-independent 
manner by enhancing the activity of the microprocessor complex, which 
increases the level of miRNA precursors pre-mir-183, -96, and -182. This 
pathway likely involves receptor-activated SMAD proteins (R-SMADs) as 
intermediates.  
 
To investigate a role for miR-183/96/182 and their regulation by nuclear PP1 in 
ARCD, their hippocampal expression was compared between young and aged 
mice. Aging increased nuclear PP1 activity in mouse hippocampus, which 
impaired the biogenesis of miR-183/96/182 at the post-transcriptional level. 
Over-expressing miR-183/96/182 in the hippocampus reversed the aging-
related decline in memory. Furthermore, miR-183/96/182 were decreased in 
the brain samples from patients with amyotrophic lateral sclerosis (ALS), a 
neurodegenerative condition characterized by TDP-43 pathology and cognitive 
dysfunction in almost 50% of the patients. In vitro studies showed that TDP-43 
regulates the microprocessor-mediated biogenesis of miR-183/96/182 in a 
PP1-dependent manner.  
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We provide novel evidence that nuclear PP1 regulates the biogenesis of 
specific miRNAs associated with memory. This regulatory pathway is 
implicated in ARCD and may contribute to cognitive dysfunction in certain 
neurodegenerative conditions.  
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Zusammenfassung 
 
Neue Erkenntnisse deuten darauf hin, dass microRNAs (miRNAs) eine Rolle in 
der Regulierung synaptischer Plastizität und Gedächtnisbildung spielen. In 
dieser Studie haben wir untersucht, ob Proteinphosphatase 1 (PP1) - ein 
potenter Gedächtnishemmer - die Bildung von miRNAs im Zusammenhang mit 
der Bildung von neuen Erinnerungen modulieren kann. Des Weiteren wurde 
untersucht, ob eine Dysregulation von PP1-abhängigen miRNAs im 
Zusammenhang mit altersbedingtem kognitiven Verfall (age-related cognitive 
decline, ARCD) steht. 
 
Um diesen Sachverhalt zu überprüfen haben wir „deep-sequencing 
screenings“ von hippokampalen miRNAs, welche während der 
Gedächtnisbildung unterschiedlich reguliert werden, durchegführt. Zudem 
haben wir dieses screening von miRNAs in einem transgenen Mausmodel mit 
verbesserter Gedächtnisbildung resultierend aus der Hemmung von nuklearem 
PP1 (NIPP1*), in Neuronen des Vorderhirns untersucht. Spezifische miRNAs, 
vor allem der miRNA cluster miR-183/96/182, wurden im Hippocampus von 
NIPP1 Mäusen differentiell exprimiert. Dieser cluster zeigte ein ähnliches 
Regulierungsmuster in wild-typ Mäusen nach Training. Überexpression des 
clusters in adultem Hippocampus der Maus verbesserte das 
Langzeitgedächtnis, wobei seine Hemmung das Erinnerungsvermögen 
beeinträchtigt hat. Mechanistische in vitro Studien zeigen, dass PP1 die 
Biogenesie von miR-183/96/182 in einer von der Transkription unabhängigen 
Art durch verbesserte Aktivität des micropossessor complexes reguliert, 
welche die miRNA Vorläufer pre-mir-183, -96 und -182 erhöht vorkommen 
lässt. Dieser Signalweg beinhaltet Rezeptor-aktivierte SMAD Proteine (R-
SMADs) als Reaktionsintermediate. 
 
Um eine mögliche Rolle der miR-183/96/182 und deren Regulation durch 
nukleares PP1 in ARCD zu untersuchen, wurde deren hippokampale 
Expression zwischen jungen und gealterten Mäusen verglichen. Nukleare PP1-
Aktivität war erhöht in gealterten Mäusen. Diese wiederum beeinträchtigte die 
Biogenese von miR-183/96/182 auf der post-transkriptionellen Ebene. 
Überexpression von miR-183/96/182 im Hippocampus wirkte dem 
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altersbedingten Gedächtnisverlust entgegen. Des Weiteren war miR-
183/96/182 Gewebeproben von Patienten mit amyotroper lateraler Sklerose 
(ALS), eine neurodegenerative Krankheit charakterisiert durch TDP-43 
Pathologie und kognitiver Dysfunktion in fast 50% der Patienten, reduziert. In 
vitro Studien konnten zeigen dass TDP-43 die „microprocessor-abhängige“ 
Biogenese von miR-183/96/182 in einer PP1-abhängigen Art reguliert. 
 
Wir legen neue Erkenntnisse vor, dass nukleares PP1 die Biogenese von 
spezifischen miRNAs, welche im Zusammenhang mit Erinnerungen stehen, 
reguliert. Dieser regulatorische Signalweg steht im engen Zusammenhang mit 
ARCD und könnte zur kognitiven Dysfunktion in bestimmten 
neurodegenerativen Krankheitsbilder beitragen. 	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 Prologue: Understanding Memory 
 
Memory formation is one of the most elegant functions of the brain that has 
been uniquely preserved among multicellular organisms, from simple creatures 
like C. elegans and Aplysia, to higher life forms like rodents and primates. The 
ability to register the information perceived by the sensory organs, storage of 
pertinent information in the context of its emotional associations, and its recall 
at a later stage is pivot of all executive functioning in humans. Memory 
formation is a precursor to almost all advanced human behaviors, ranging from 
language development to economic decision making. Indeed, who we are is 
defined by an intertwined collection of learning experiences. When the ability to 
learn is impaired in neurodevelopmental disorders, or when new memories 
cannot be formed and/or old ones are forgotten in neurodegenerative 
conditions or with aging, it leads to extreme morbidity in humans. Therefore, 
understanding how memories are formed in the brain, discovering which 
internal and external factors can impair this quintessential brain function, and 
unveiling any possibilities to preserve this astonishing feat are subjects of 
considerable neuroscience research. 
 
Memory formation is a complex process, which employs diverse biological 
pathways based on its temporal persistence, the accompanying emotional 
responses, and the nature of the information stored. Based on its temporal 
persistence, memory can be classified as short-term memory (STM), lasting 
from seconds to hours, and long-term memory (LTM), persisting for days to 
years (Kandel et al. 1986). Based on its nature, memory can be declarative, a 
recallable collections of facts and events, or procedural, a learning of skills or 
habit development. From a neuropsychological perspective, memory formation 
can be divided into three inter-dependent processes: memory encoding/ 
consolidation, which involves registration and storage of information; memory 
retrieval, which means recall of the memory trace; and memory 
reconsolidation, which refers to the subsequent modification of the originally 
stored memory trace (McKenzie & Eichenbaum, 2011).  
 
Our understanding about the brain regions controlling declarative LTM 
formation benefited enormously from the study of Henry Gustav Molaison, 
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widely known as patient H.M. H.M. underwent medial temporal lobectomy as a 
treatment for temporal lobe epilepsy, resulting in bilateral resection of anterior 
two thirds of his hippocampi, para-hippocampi, entorrhinal cortices, and the 
amygdalae. The surgery impaired H.M.’s ability to form long-term memories, 
with relative sparing of short-term and procedural memories (Scoville & Milner, 
1957). Subsequent neuropsychological studies on H.M. established medial 
temporal lobe (MTL) as a critical memory system in the brain. To date, MTL, 
and in particular hippocampal formation, remain the most widely studied brain 
region in the context of learning and memory (Bird & Burgess, 2008). However, 
it must be mentioned that other brain regions, such as frontal cortex, may have 
important contributions to some forms of memory as well (Tronson & Taylor, 
2007).  
 
In this thesis, together with the help of my colleagues, I have attempted to 
further our knowledge about the molecular underpinnings of memory formation 
in mammals, and decipher pathways leading to its impairment with aging and 
in some disease conditions. I will introduce the elaborate mechanisms 
underlying LTM formation in the first chapter, and present our hypothesis about 
a potential role for protein phosphatase 1 (PP1) and micro RNAs (miRNAs) in 
their regulation. The second chapter will describe how certain miRNAs regulate 
memory in a PP1-dependent manner, a detailed investigation, which has now 
been accepted for publication in Nature Communications. The third chapter 
investigates a role for PP1 and miRNAs in memory impairment associated with 
aging and certain neurodegenerative conditions. This investigation has been 
written as a brief communication format. Finally, I have elaborated on the 
salient outcomes of my work in the ‘Discussion’ chapter, with an emphasis on 
the clinical implications of this thesis, and a plan for future investigations in the 
field.  
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1. Introduction 
  
1.1. Molecular basis of memory 
Memory formation is an intricate process involving tightly orchestrated 
sequence of molecular events, culminating into changes in neuronal 
communication (reviewed in Johansen et al. 2011, Kandel 2012). These 
changes reflect in the form of altered synaptic strength in an activity-dependent 
manner, known as synaptic plasticity (reviewed in Johansen et al. 2011). 
Depending on the frequency and timing of the stimulation, and the 
neuroanatomical regions it actives, neuronal signaling can either enhance 
synaptic transmission- long-term potentiation (LTP), or depress synaptic 
transmission – long-term depression (LTD). These electrophysiological 
changes are governed by unique signaling pathways, in which protein kinases 
and phosphatases occupy critical positions (Giese & Mizuno 2013, Baumgärtel 
& Mansuy 2012, Mansuy & Shenolikar 2006). Neuronal depolarization-induced 
entry of Calcium (Ca2+) in neurons activates several kinases such as 
Ca2+/Calmodulin dependent kinase II (CamKII), protein kinase C (PKC), protein 
kinase A (PKA), as well as, protein phosphatases protein phosphatase 1 
(PP1), and Calcineurin (CaN). Together, these kinases and phosphatases 
regulate the expression and activity of important synaptic proteins, including 
synaptic receptors, channels, neurotransmitter, and neuromodulators (Kandel 
2012, Baumgärtel & Mansuy 2012). For example, phosphorylation of different 
sub-units of N-methyl-D-aspartate (NMDA) receptors regulates their 
functionality (Sanz Clemente et al. 2012). Similarly, phosphorylation of different 
post-synaptic protein complexes such as post-synaptic density 95 (PSD95) 
and actin cytosekeleton control the response to synaptic activation (Nelson et 
al. 2013, Bertling et al. 2016). Further to these transient changes in protein 
expression and activity, de novo synthesis of proteins has been established as 
the hallmark signature of LTM (reviewed in Hernandez & Abel 2008).  
 
Neuronal activity-induced formation of new proteins starts with translocation of 
the signals to the nucleus through second messenger molecules, where 
transcription factors critical for memory, such as cAMP- response element 
binding protein (CREB) are activated (reviewed in Johansen et al. 2011). The 
activation of these transcription factors directly or indirectly implicates neuronal 
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kinases CamKII, PKC, PKA, and phosphatases PP1 and CaN (reviewed in 
Johansen et al. 2011). These nuclear signaling events lead to transcription of 
multiple genes, including immediate early genes (IEGs), signaling molecules, 
as well as, components of the synaptic machinery (Loebrich & Nedivi, 2009). 
Importantly, many IEGs, such as c-Fos are transcription factors themselves, 
thus starting a cascade of de novo synthesis of cellular molecules, which is 
stringently regulated at each step (Ramirez-Amaya 2007).  
 
Following transcription, the newly transcribed mRNAs are carried to the 
translational machinery components, in the neuronal soma and synapses for 
protein synthesis. Importantly, the process of mRNA transport, translation, as 
well as, the ensuing expression, activity, stability, and degradation of proteins 
are highly regulated in an activity-dependent manner (reviewed in Hernandez 
& Abel 2008).  
 
1.2. Molecular basis of memory: the concept of memory inhibitors 
It has been long argued that the brain needs an elaborate mechanism to 
prevent formation of useless or harmful memories (Silva & Josselyn, 2002). 
Indeed, amnesia for factual details of the event is extremely common in 
individuals exposed to trauma (reviewed in Brewin & Holmes, 2003, and 
Dalgleish, 2004). Similarly, it has been argued that forgetting in old age is 
attributed to impaired inhibition of memorizing useless details (Hedden et al. 
2001).  
 
The hypothesis that memory systems in the brain simultaneously employ 
memory-promoting and memory-suppressing pathways in a ‘yin’ and ‘yang’ like 
fashion to optimize formation of pertinent memories is well supported by 
electrophysiological and molecular studies. At the electrophysiological level, 
neuronal activity can induce the markedly contrasting LTP and LTD in the 
hippocampus, depending on the nature of the stimulation. Neuronal activity in 
the form of novel object exploration enhances LTP (Davis et al. 2004), whereas 
neuronal activity involving behavioral stress enhances LTD (Yang et al. 2005). 
Similarly, at the molecular level, a handful of memory suppressor molecules 
have been discovered in the last two decades. These memory suppressors 
constrain memory through a multitude of mechanisms; inhibiting the activity of 
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memory promoting transcription factors, interfering with relay of neuronal 
signaling underlying memory formation, or through blocking the expression of 
synaptic proteins (Table 1.1). 
 
Table 1.1: Important molecular inhibitors of memory  
Memory 
suppressor 
Major memory suppressing mechanism(s) Major Reference(s) 
CREB-2 Inactivation of CREB-1 Bartsch et al. 1995, 
Abel et al. 1998, 
Chen et al. 2003 
Calcineurin Suppression of glutamate receptors and Ziff268 
 
Mansuy et al. 1998, 
Malleret et al. 2001, 
Baumgärtel et al. 
2008 
PP1 Epigenetic transcriptional inhibition of CREB and NFkB  Genoux et al. 2002, 
Kushibu et al. 2009,  
miR-124 
 
 
miR-134 
 
miR-137 
 
miR-980 
Post-transcriptional inhibition of CREB, Reduction in 
AMPA receptors 
 
Post-transcriptional inhibition of BDNF 
 
Impairment of pre-synaptic neurotransmitter release 
 
Translational repression of autism susceptibility gene 
A2bp1 
Rajasethupathy et 
al. 2009, Dutta et al. 
2013 
 
Gao et al. 2010 
 
Siegert et al. 2015 
 
Guven-Ozkan et al. 
2016 
HDACs Transcriptional suppression of memory-promoting genes Guan et al. 2009, 
Gräff et al. 2013 
SLC22A 
transporter 
Inhibitor of cholinergic signaling Gai et al. 2016 
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1.3. Protein Phosphatases as epigenetic suppressors of memory 
Protein phosphatases CaN and PP1 are key molecular regulators of memory 
that constrain learning. Both phosphatases are highly abundant in the brain, 
and when they are exclusively suppressed in the adult mouse forebrain by 
induction of specific inhibitors, memory formation is enhanced (Genoux et al. 
2002, Malleret et al. 2001). On the other hand, increase in their activity in the 
brain experimentally or naturally during aging induces forgetting (Mansuy et al. 
1998, Park et al. 2015). This is corroborated by experimental evidence 
showing that both CaN and PP1 regulate major forms of synaptic plasticity in 
the hippocampus and the amygdala (Jouvenceau et al. 2006, Winder et al. 
1998, Malleret et al. 2001, Koshibu et al. 2011). 
 
Off note, PP1 exerts its regulatory effect on memory through changes in the 
epigenome (Koshibu et al. 2009, 2011). Epigenetic changes, such as 
modifications of the histone code and chromatin remodeling accompany the 
effects of PP1 on memory at the behavioral level (Koshibu et al. 2009). These 
functions are mediated by the dephosphorylating action of PP1 on histone H3, 
as well as, modulation of other histone post-translational modifications (PTMs). 
Through these mechanisms, PP1 can act as a major transcriptional regulator 
during memory formation, regulating the RNA polymerase II (RNA pol II) 
occupancy at the promoter of CREB (Genoux et al. 2002).  
 
Further to transcriptional regulation of memory-relevant gene expression, PP1 
may modulate the expression of memory genes at the post-transcriptional 
level. Consistently, comparative analyzes of transcriptional and proteomic 
changes (measured by high throughput proteomic analyses) resulting from 
PP1 inhibition in the mouse hippocampus reveals a large dissociation between 
the two (unpublished data), strongly suggesting that post-transcriptional 
mechanisms of regulation operate in addition to transcriptional regulation to 
mediate the memory enhancing effect of PP1 inhibition.  
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1.4. Post-transcriptional regulation of gene expression in memory 
formation: Role of microRNAs  
Formation and storage of LTM involve dynamic changes in the synaptic 
strength of neurons. Post-transcriptional gene regulation is particularly 
important for synaptic plasticity, as it provides a rapid and dynamic mode of 
control of synaptic proteins (Wang et al. 2012). This mode of control can be 
largely mediated by microRNAs (miRNAs/miRs), a class of small non-coding 
RNAs (20-22nt), which can regulate multiple targets through translational 
repression or degradation of their mRNAs (reviewed in Krol et al. 2010).  
 
There is a strong biological rationale supporting a critical role for miRNAs in 
post-transcriptional regulation of memory-relevant gene expression. Many 
miRNAs are expressed in the brain, mostly in a region specific manner. Their 
biogenesis, functions, and turnover allow for a rapid and reversible regulation 
of gene expression (Wang et al. 2012). Typically, a single miRNA can target 
multiple mRNAs, allowing for a combinatorial regulation of gene expression 
(Krol et al. 2010), suitable for a phylogenetically superior brain function, such 
as memory formation.  
 
Neuronal activity, the harbinger to memory formation, alters the expression of 
several miRNAs in brain regions governing cognitive functions, such as 
hippocampus, frontal cortex, and the amygdala. Importantly, the predicted 
targets of these miRNAs often contain a considerable proportion of synaptic 
proteins (Sim et al. 2014).  Neuronal synapses are enriched for components of 
miRNA biogenesis machinery, as well as, the RNA induced silencing complex 
(RISC), where miRNAs can potentially regulate the synthesis of around 90% of 
the known synaptic proteins. (Paschou et al. 2012)  
 
When components of miRNA biogenesis complex are experimentally 
suppressed or over-expressed, they perturb memory. Reduced synaptic 
expression of Armitage, a component of the RISC complex, impairs LTM 
formation in Drosophila (Ashraf et al. 2006). Similarly, conditional knockout of 
Dicer in the forebrain neurons enhances fear memory in mice (Konopka et al. 
2010).  
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Furthermore, individual miRNAs are known to regulate different forms of 
memory (Saab & Mansuy, 2014, Table 2). The most widely characterized 
miRNAs in this regard are miR-212 and miR-132 (genomically expressed as a 
single cluster, miR-212/132), which are up regulated in the hippocampus 
during memory formation in mice (Wayman et al. 2008, Hansen et al. 2010). 
Further, hippocampal up regulation of miR-132 at levels comparable to 
physiological memory formation enhances learning in mice, whereas their 
excessive over-expression impairs memory (Wang et al. 2013). At the cellular 
and molecular level, miR-212/132 cluster regulates dendritogenesis, dendritic 
arborization, and LTP (Luiqart et al. 2010, Magill et al. 2010, Remenyl et al. 
2013). Similarly, impairment of LTP and formation of long-term fear memory 
are observed in mice after hippocampal over-expression of miR-134 (Gao et al. 
2010). Besides these, miR-34a, miR-128b, miR-182, miR- 137, miR-9, and 
miR-980 have also been shown to regulate the molecular mechanisms 
underlying LTP and/or memory formation (Table 2). Generally, these miRNAs 
contribute to memory formation by regulating the synthesis of cytoskeleton 
components, transcription factors, and trophic factors, which are responsible 
for dendritic remodeling, synaptogenesis, and synaptic plasticity (Saab & 
Mansuy, 2014, Woldemichael & Mansuy, 2016). Overall, the regulatory 
networks established by miRNAs in the brain allow them to play a critical role 
in memory formation and cognitive functions (Wang et al. 2012). However, 
although their contribution is well established, their mechanism of action, and 
particularly modes of regulation remain mostly unknown.    
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Table 1.2: Major memory-regulating miRNAs 
miRNA Key memory-relevant 
target(s) 
Role in memory Species Major 
Reference(s) 
miR-124 CREB, Zif268 First memory suppressor 
miRNA identified 
Aplysia, 
mouse 
Rajasethupathy 
et al. 2009, Yang 
et al. 2009 
miR-128b CREB1, Ppp1cc Regulation of fear 
extinction memory 
Mouse Lin et al. 2011 
mir-132/212 MeCP2 Bidirectional regulation of 
hippocampal memory 
Mouse, rat Hansen et al. 
2010, Scott et al. 
2012, Wang et al. 
2013, 
Hernandez-Rapp 
et al. 2015, 
Hansen et al. 
2016 
mir-134 BDNF, Limk 1 Suppresses hippocampal 
memory 
Mouse Gao et al. 2010 
mir-182 Cortactin, RAC1 Suppresses auditory fear 
memory 
Mouse Griggs et al. 2013 
miR-34a Notch signaling Promotes fear memory 
consolidation  
Mouse Dias et al. 2014 
miR-92 KCC2, CPEB3, MEF2D Promotes contextual fear 
memory 
Mouse Vetere et al. 2014 
miR-137 CPLX1, NSF, SYT1 Supresses hippocampal 
memory 
Mouse Siegert et al. 
2015 
miR-9 Genes involved in cell-
adhesion, endocytosis, and 
cell-death 
Suppresses spatial-
memory 
Mouse Malmevik et al. 
2016 
miR-980 A2BP1 Suppresses olfactory 
memory 
Drosophila Guven-Ozkan et 
al. 2016 
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1.5. Biogenesis of miRNAs 
Most miRNAs are produced through the well-characterized canonical pathway 
of miRNA biogenesis in the cells, involving both transcriptional and post-
transcriptional steps (reviewed in Ha & Kim, 2014).  
 
Nuclear Biogenesis 
In mammals, miRNAs are mostly encoded by genomic introns of both protein 
coding and non-coding genes. When miRNA sequences are present in the 
introns of protein-coding genes, they may share the transcriptional promoters 
with the host genes. However, a substantial number of miRNA promoters, 
distinct from the promoters of the host genes, have now been identified 
(Ozsolak et al. 2008, Monteys et al. 2010).   
 
In some cases, individual miRNA sequences exist in close proximity to each 
other forming polycistronic transcription units (Lee et al. 2002). miRNAs 
belonging to the same cluster, are often functionally identical with over-lapping 
targets. Members of a cluster are usually co-transcribed, but can be subjected 
to distinct post-transcriptional regulations (Ha & Kim, 2014). 
 
miRNA sequences are transcribed mostly by RNA pol II, and occasionally by 
RNA pol III (Cai et al. 2004, Lee et al. 2004, Pfeffer et al. 2005). The product of 
transcription is a double stranded (ds) long (>1 kb) RNA molecule called 
primary miRNA (pri-mir/pri-mirna).  A typical pri-mir consists of a stem 
containing the mature miRNA sequence, a terminal loop, and single-stranded 
RNA segments at each end (Fig. 1.1). 
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Fig.1.1. Structure of a primary microRNA containing the stem, terminal loop, and the 
single-stranded RNA segments at each end (adapted from Ha & Kim, 2014). Drosha 
along with DGCR8 cleaves the stem from the single-stranded RNA segments 
approximately 11 bp from the basal junction. The resulting pre-mirna undergoes 
further cleavage by Dicer, which removes the terminal loop to produce the mature 
miRNA guide and passenger strands.  
 
The ds-stem of pri-mir is critical for its recognition and processing by Drosha, a 
nuclear RNAase III endonuclease vital for miRNA biogenesis (reviewed in Lee 
et al. 2002, Ha & Kim, 2014). The carboxy-terminal (C-terminal) of Drosha is 
essential for its primarily nuclear localization (Tang et al. 2010), whereas its 
RNA-binding and RNAse functions are related to its amino-terminal (N-
terminal) (Gregory et al. 2004). Drosha requires the aid of another nuclear 
protein DiGeorge syndrome critical region 8 (DGCR8) for its binding to ds-RNA 
(Han et al. 2006). Together, Drosha and DGCR8 form a complex in the 
nucleus, known as the microprocessor complex, which is indispensible to 
miRNA biogenesis (Gregory et al. 2004, Han et al. 2006). The microprocessor 
cleaves the pri-mir hairpin at approximately 11 bp from the basal junction of the 
Terminal loop 
Apical junction 
Basal junction 
Drosha cleavage site 
Upper stem     21 bp 
Lower stem     11 bp 
5’ 3’ 
Dicer cleavage site 
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stem to generate the ds- precursor miRNA (pre-mir) in a sequence-
independent manner (Zeng & Cullen, 2005, Fig. 1). 
 
As the functioning of the microprocessor is crucial for miRNA biogenesis, its 
expression, activity, and specificity are tightly regulated through complex 
mechanisms (reviewed in Ha & Kim, 2014, Fig. 2). These include a 
homeostatic cross-regulatory loop between Drosha and DGCR8, where 
DGCR8 stabilizes Drosha, whereas Drosha destabilizes DGCR8 mRNA levels 
to prevent its over-expression  (Yeom et al. 2006, Han et al. 2006). Further to 
this auto-regulatory loop, Drosha and DGCR8 expression and nuclear 
localization depend on PTMs, such as phosphorylation (Tang et al. 2010, Tang 
et al. 2011, Herbert et al. 2013, Yang et al. 2015) and acetylation (Wada et al. 
2012, Tang et al. 2013).  
 
Similarly, the microprocessor processing can be selectively enhanced or 
diminished for certain miRNA by the action of some microprocessor 
‘accessory’ proteins. These proteins are generally RNA binding proteins that 
selectively interact with Drosha and/or certain pri-mirs in a sequence-
dependent manner (reviewed in Ha & Kim, 2014, Fig. 2). Notably, nuclear 
proteins p68 and p72 control the biogenesis of a subset of miRNAs by 
associating with the microprocessor (Fukuda et al. 2007). Some other proteins, 
such as receptor-activated SMAD proteins (R-SMADs) and p53 promote 
microprocessor activity through their interaction with p68 (Davis et al. 2008, 
Suzuki et al. 2009, Davis et al. 2010).  Another DNA/RNA binding protein TAR 
DNA-binding protein of 43 kDa (TDP-43) interacts with Droscha to specifically 
promote the biogenesis of a few miRNAs (Kawahara et al. 2012, Di Carlo et al. 
2013). Further to these, the microprocessor activity can be selectively 
modulated by heterogeneous nucleus ribonucleoprotein A1 (HNRNPA1), KH 
type spilcing regulatory protein (KSRP), and LIN28 (Guil et al. 2007, Trabucchi 
et al. 2009, Qiao et al. 2012, Fig. 1.2) 
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Fig.1.2. Schematic model of miRNA nuclear biogenesis and export into the cytoplasm 
with examples of how miRNA biogenesis can be regulated post-transcriptionally 
(reprinted from Ha & Kim, 2014).   
 
Nuclear Export 
Following Drosha processing, pre-miRNAs are exported into the cytoplasm 
through non-selective nuclear transporter exportin 5 (EXP5). EXP5 forms a 
transport complex with RAN-GTP and pre-mir, releasing the pre-mirna into the 
cytoplasm after GTP hydrolysis (Yi et al. 2003, Bohnsack et al. 2004, Lund et 
al. 2004). Knockdown of the gene encoding EXP5 results in reduction in 
miRNA levels, surprisingly without an accumulation of pre-mirs in the nucleus, 
suggesting that excessive pre-mirs in the nucleus are possibly degraded by 
endonucleases (Yi et al. 2003). Mechanisms governing the nuclear export of 
pre-mirs, and its disease-relevance remain poorly investigated as of now. 
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Cytoplasmic Biogenesis  
In the cytoplasm, pre-mirs undergo cleavage at their terminal loops by another 
RNAse III enzyme Dicer (reviewed in Ha & Kim, 2014). Similar to Drosha, N-
terminal of Dicer is used for pre-mir identification and binding to their terminal 
loops (Gu et al. 2012), whereas its C-terminal carries the RNAse function 
(Zhang et al. 2002, Zhang et al. 2004).  
 
Conversion of pre-mir into mature miRNAs by Dicer is fundamentally a non-
selective process. However, proteins that interact with Dicer to confer 
selectivity to its processing have been identified (reviewed in Ha & Kim 2014). 
Most notable, among these proteins is TAR RNA binding protein (TRBP), 
which promotes the Dicer processing for a miRNA subset, and also modulates 
their length (Fukunaga et al. 2012, Wilson et al. 2015, Lee et al. 2012). 
Mutations of TARBP2, the gene coding TRBP leads to altered miRNA profile in 
many cancer types (Melo et al. 2009). Further to TRBP, many other RNA 
binding proteins, like TDP-43, KSRP, and LIN28 also affect the activity of Dicer 
(Ha & Kim, 2014). Finally, Dicer expression seems to be homeostatically 
regulated by the level of mature miRNAs present in the cell, as there are 
binding sites of let-7 miRNA on Dicer mRNA, providing a negative feed-back 
loop for keeping Dicer expression and activity in check (Tokumaru et al. 2008, 
Jakymiw et al. 2010).    
   
1.6. Functions of microRNAs 
Upon completion of Dicer processing, dsRNAs of 20-24 nt length are 
generated. One of these two strands, the guide strand, is loaded into the 
miRISC complex, whereas the other stand, the passenger strand, is degraded 
by nucleases (reviewed in Ha & Kim, 2014). The strand selection for RISC 
loading depends on the thermodynamic properties of the strands, with a 
preferential loading of the strand with weaker 5’ end pairing (Meister, 2013, 
Yates et al. 2013).  
 
The miRISC complex comprises argonaute (AGO) protein and its partner 
GW182. Together these proteins interact with the miRNA and guide the 
complex to its target mRNAs (Mesiter, 2013). The binding between the 
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miRNAs and their targets is usually partially complementary, and depends on 
the miRNA seed sequences. mRNA targets usually, but not always, contain a 
target partially matching the miRNA seed sequence in their 3’UTR (Fabian et 
al. 2010, O’ Carroll & Schaefer, 2013). The recruitment of targets mRNAs by 
the miRISC complex results in their translational repression or degradation. 
miRNAs inhibit the translation of their target mRNAs by interfering with the 
assembly of translational machinery. This includes impairment in the target 
mRNA association with eIF4G, ribosomal subunits, and translational elongation 
factors (Wilczynska & Bushell, 2015). Similarly, miRNAs can degrade their 
targets through recruitment of deadenylase complexes, which remove poly-A 
tails from the mRNAs, rendering them vulnerable to the exonuclease attack 
(Fabian et al. 2010, Fabian & Sonenberg, 2012).  
 
The extent of target gene suppression by miRNAs is determined by several 
factors, including the baseline expression of miRNAs and their targets, as well 
as, presence of competitive endogenous RNA sponges, such as long non-
coding RNAs (lncRNAs) (Wilczynska & Bushell, 2015, Thomson & Dinger, 
2016). Single cell analysis of miRNA-mediated target suppression suggests 
that this suppression is determined by a minimal threshold expression of the 
target gene. Target expression below this threshold leads to a stronger 
suppression by miRNAs, thus enabling the miRNAs to act as a biological 
switch, which needs to be turned off to allow expression of the target. Contrary 
to this, when a target is expressed in abundance, the miRNA suppression is 
minimal and only used for fine-tuning (Mukherji et al. 2011). Further to that, 
many miRNAs function in a combinatorial fashion to suppress functionally 
identical mRNAs, and hence the level of suppression of a single target may not 
fully reflect the functional effect of miRNA manipulation (Balaga et al. 2012) 
 
1.7. miRNA Degradation 
The stability of mature miRNAs depends on their 5’ and 3’ thermodynamicity, 
as well as, the association between miRNAs and their mRNA targets (reviewed 
in Ha & Kim, 2014). Untemplated addition of adenosine or uracil residues at 3’ 
miRNA ends renders them unstable (Heo et al. 2009, Jones et al. 2009). 
Similarly, when miRNAs are not bound to their targets, they are unloaded from 
the RISC complex through the action of exoribonucleases Xrn-1 and Xrn-2, 
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and rapidly degraded in the cytoplasm (Chatterjee & Grosshaus 2009, 
Finnegan & Pasquinelli 2013). Although, not much is known about the modes 
of miRNA degradation, emerging evidence suggests that a number of miRNAs 
exhibit dynamic turn-over (Krol et al. 2010, Gantier et al. 2011). This dynamic 
turn-over is an intrinsic property of a sizable fraction of brain miRNAs, which 
undergo simultaneous decrease and transcriptional increase in response to 
neuronal activity (Krol et al. 2010).              
 
1.8. Regulation of microRNA biogenesis and functions: Potential role of 
PP1 
While miRNAs are important regulators of memory processes, their biogenesis 
and activity can in turn, be potentially controlled by molecular mechanisms 
implicated in memory, such as protein phosphatases.  
 
Protein phosphatases govern the activity of many transcription factors, some of 
which may regulate the transcription of miRNAs. For example, transcription 
factor CREB, which is potentially under the control of PP1 (Genoux et al. 2002, 
Koshibu et al. 2009), was shown to up-regulate miR-132 during activity-
dependent synaptic remodeling (Nudelman et al. 2010). Similarly, nuclear 
factor kappa-light-chain-enhancer of activated B cells (NFkB), a transcription 
factor inhibited by PP1 (Gu et al. 2014), increases the expression of miR-125b 
and miR-146a (Pogue et al. 2009, Hill et al. 2015).    
 
Further, protein phosphatases can post-transcriptionally regulate miRNA 
biogenesis through altering the phosphorylation-dependent expression and 
activity of major components of the miRNA biogenesis machinery. These 
include Drosha, DGCR8, TRBP, and AGO proteins of the miRISC complex. 
Sub-cellular localization, stability and activity of Drosha and DGCR8 depend on 
phosphorylation/dephosphorylation of their C- and N-terminals (Tang et al. 
2010, Tang et al. 2011, Herbert et al. 2013). Similarly, phosphorylation of 
TRBP generates miRNAs with greater stability (Paroo et al. 2009). Finally, 
phosphorylation of human AGO proteins controls the loading of miRNAs into 
the miRISC complex (Rüdel et al. 2011).  
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Given the dependence of the miRNA biogenesis machinery on 
phosphorylation, and the known link between protein phosphatases and 
memory formation, it is postulated that PP1 can impact the biogenesis and 
activity of miRNAs during memory formation. Further to that, it is critical to 
study the involvement of this regulatory pathway in conditions associated with 
memory impairment in humans.   
 
1.9. Age Related Cognitive Decline (ARCD): Potential Involvement of PP1 
and miRNAs 
Aging is associated with a progressive impairment of learning abilities and 
memory formation, which can be a cause of considerable morbidity in the 
elderly. These deficits in memory vary in their manifestation and severity, 
ranging from occasional lapses in memory- ‘senior moments’, to widespread 
deficits in multiple cognitive domains (reviewed in Hedden et al. 2004, Konar et 
al. 2016). Longitudinal studies on brain functioning in the elderly reveal 
progressive deficits in especially episodic LTM (Hedden et al. 2001, Nillson et 
al. 2003, Hedden et al. 2004). These deficits occur without any clear indication 
of Alzheimer disease (Petersen et al. 2006, Jicha et al. 2006), and hence do 
not implicate neurodegeneration as the major underlying mechanism.  
 
The exact molecular mechanisms underlying age related cognitive decline 
(ARCD) remain elusive. There are multiple reasons to believe that memory 
inhibitor PP1 could be implicated in ARCD. First, the activity of PP1 in 
hippocampal neurons increases with age in mice (Park et al. 2015). Second, 
transgenic inhibition of PP1 in forebrain neurons prevents age-related 
impairment of LTM in mice (Genoux et al. 2002). Third, strategies known to 
partially reverse or delay ARCD in mice, such as environment enrichment 
decrease PP1 activity in the brain (Park et al. 2015). 
 
Similarly, a number of studies suggest a possible involvement of miRNAs in 
ARCD (Kosik et al. 2012). A deep sequencing comparison of whole brain 
miRNA expression between young and aged mice, showed a differential 
expression of 93 miRNAs with aging (Inukai et al. 2012). Recently, it has also 
been questioned if aging also impairs miRNA functioning by affecting their 
loading in the miRISC complex (Gregoriev & Bonini, 2014). 
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Based on the possible involvement of PP1 in miRNA regulation for memory 
formation, it becomes critical to ascertain if age-induced changes in activity of 
PP1 impair miRNA biogenesis and/or functioning to cause ARCD.   
 
1.10. Cognitive Dysfunction associated with neurodegenerative 
disorders: Potential Involvement of PP1 and miRNAs 
Increase in human life span during the last few centuries has resulted in a 
growing epidemic of neurodegenerative disorders, notably Alzheimer disease 
(AD), frontotemporal lobar degeneration (FTLD), Parkinson disease (PD), and 
amyotrophic lateral sclerosis (ALS). A common feature of these 
neurodegenerative disorders is abnormal intra-cellular and/or extra-cellular 
aggregation of proteins in the central nervous system (CNS) (reviewed in Ross 
& Poirier, 2004, Table 3). These deposits may be a result of genetic mutations 
in a fraction of familial cases, but the molecular mechanisms underlying these 
protein deposits in majority sporadic cases remains unclear. Down-stream to 
abnormal protein deposition, multiple pathways are activated, which are 
responsible for neuronal death and the clinical manifestations of these 
disorders. These include, notably, oxidative damage, glutamate excitoxicity, 
and apoptosis (reviewed in Byrne et al. 2011).  
 
Memory impairment, as a component of the constellation of neuropsychiatric 
symptoms collectively called dementia, is a cardinal feature of 
neurodegenerative disorders (Table 1.3). Both the human patients and animal 
models of neurodegenerative disorders have deficits in memory prior to any 
obvious indication of neuronal death (Rapp et al. 2002, Spires et al. 2006, Ford 
et al. 2015). Similarly, synaptic dysfunction precedes formation of senile 
plaques and neuronal death in models of AD (Wirths & Bayer, 2010). Further, 
brain amyloid beta deposits in these models interfere with the cascade of 
enzymes required for activation of memory promoter CREB (Vitolo et al. 2002, 
Arvanitis et al. 2007). Finally, a recent study revealed an epigenetic blockade 
on LTM formation in a mouse model of AD (Gräff et al. 2012).  
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Table 1.3: Pathological and Cognitive characteristics of common 
neurodegenerative disorders.  
 
 
There are multiple reasons to query if cognitive dysfunction in 
neurodegenerative disorders implicates PP1 and miRNAs. An alteration of 
phosphatases and kinases may underlie the pathogenesis of multiple 
neurodegenerative disorders, as the pathological protein aggregates in these 
are often phosphorylated. This is the case, notably, for TDP-43 aggregates in 
ALS and FTLD (Neumann et al. 2006), fused in sarcoma (FUS) aggregates in 
FTLD (Neumann et al. 2009), tau aggregates in FTLD and other taupathies 
(Stanford et al. 2004), and alpha-synuclein (α-synuclein) aggregates in PD 
(Wang et al. 2012). Importantly, some of these proteins, for example TDP-43 
Neurodegenerative 
disorder 
Pathological 
Neuronal aggregation 
Severity and nature of cognitive impairment 
Alzheimer disease 
(AD) 
Senile plaques 
(amyloid β) 
Neurofibrillary tangles 
(Tau) 
Early deficits in LTM progressing to dementia 
Parkinson disease 
(PD) 
Lewy bodies (α-
synuclein) 
Deficits in working memory in late stages 
Lewy body dementia 
(LBD) 
Lewy bodies (α-
synuclein) 
 
Senile plaques 
(amyloid β) 
Fluctuating deficits in STM, and/or working memory 
Frontotemporal lobar 
degeneration (FTLD) 
Tau (FTLD-Tau) 
 
TDP-43 (FTLD-TDP) 
 
FUS (FTLD-FUS) 
Clinically sub-divided into behavioral variant FTD (deficits 
in working memory and executive functioning) or language 
variant FTD (deficits in language functioning or semantics). 
All variants show varying deficits in STM and LTM 
Amyotrophic lateral 
sclerosis (ALS) 
TDP-43 Progressive cognitive dysfunction similar to FTLD in 50% 
patients, severe enough to be classified as dementia in 
20% 
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and FUS also regulate the expression or activity of some phosphatases 
(Perera et al. 2014, Schwartz et al. 2012).  
 
Similarly, TDP-43 and FUS regulate the activity of Drosha and Dicer 
(Kawahara et al. 2012, Di Carlo et al. 2013), thus making impaired miRNA 
biogenesis a candidate mechanism underlying cognitive dysfunction in 
neurodegenerative disorders. Indeed, TDP-43 and FUS proteinopathies have 
distinct miRNA expression profiles in the brain (Freischmidt et al. 2013, 
Modigliani et al. 2014).   
 
Based on the aforementioned regulation of protein phosphatases and miRNAs 
by some proteins implicated in neurodegenerative disorders, it becomes 
important to study their role as mediators of cognitive dysfunction in the 
neurodegenerating brain.  
 
1.11. Experimental aims 
The main objectives of this thesis were to identify the major miRNAs that are 
regulated during LTM formation, and determine whether they are regulated by 
PP1-dependent pathways. Our particular focus was on the nuclear effect of 
PP1, since the early biogenesis of miRNAs occurs in the nucleus (Ha & Kim, 
2014), and many neurodegenerative disorders hypothetically result from the 
loss of nuclear function of the pathologically aggregated proteins (Winklhofer et 
al. 2008). For this purpose, we initially took advantage of a transgenic mouse 
model of nuclear PP1 inhibition established in the Mansuy lab in which PP1 is 
inhibited selectively in the nucleus of forebrain neurons by expression of 
NIPP1*. In these mice, PP1 inhibition improves several forms of LTM (Koshibu 
et al. 2009). Further, we studied the activity of nuclear PP1 and its effect on 
miRNA biogenesis in aged (20-21 months old) wild-type mice, which show 
impairment in LTM (Pavlopoulos et al. 2013).  The in vivo work in these mice 
was complemented by mechanistic studies on mouse neuroblastoma cells 
(N2a). We postulate that PP1 participates in the post-transcriptional control of 
gene expression in memory formation by regulating the level of memory-
relevant miRNAs, and this pathway is likely implicated in ARCD and cognitive 
dysfunction in some neurodegenerative disorders. To investigate this 
hypothesis, we set the following experimental aims.   
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1) Identifying the miRNAs that are relevant for memory formation and are 
regulated by nuclear PP1  
2) Identifying the targets of the miRNAs regulated by nuclear PP1 
3) Functionally validating the role of these miRNAs in memory formation 
4) Ascertaining the pathways by which PP1 regulates miRNA expression  
5) Investigating if these miRNAs are associated with age-related memory loss 
and early cognitive dysfunction associated with certain neurodegenerative 
disorders   
 
The first four experimental aims are addressed in Chapter 2 of this thesis, 
whereas, the fourth experimental aim is further elaborated on, and 
experimental aim 5 is exclusively covered in the Chapter 3. 
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2.1. Abstract 
Memory formation is a complex cognitive function regulated by coordinated 
synaptic and nuclear processes in neuronal cells. In mammals, it is controlled 
by multiple molecular activators and suppressors, one of which is protein 
phosphatase 1 (PP1), a signaling and transcriptional regulator that can also act 
as an epigenetic modulator. Here, we show that memory control by PP1 
involves the microRNA cluster miR-183/96/182, and that this cluster is 
selectively regulated during memory formation. Inhibiting nuclear PP1 in 
neurons in adult mice in vivo or training wild-type animals on an object 
recognition task similarly increases the level of miR-183/96/182 in the 
hippocampus. Mimicking this increase by overexpressing miR-183/96/182 in 
the hippocampus enhances object memory, while suppressing endogenous 
level of the cluster reduces it. This effect involves the modulation of plasticity-
related genes, signaling molecules and enzymes, and HDAC9 is identified as 
one of the functional targets. Further, PP1 controls these miRNAs in a 
transcription-independent manner involving the microprocessor-mediated 
generation of their precursors. These findings provide novel evidence for a key 
role for miRNAs in memory formation and newly suggest the implication of PP1 
in miRNAs processing in the adult brain.  
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Main text 
2.2. Introduction 
The formation of long-term memory depends on synaptic plasticity and on 
activity-dependent structural and functional changes in neuronal circuits.  It is 
sustained by cascades of tightly orchestrated signaling molecules that 
positively or negatively regulate synaptic efficacy for the control of memory 
formation 1,2. One of the ultimate functions of these signaling cascades is the 
regulation of gene expression and the synthesis of new proteins necessary for 
the formation and the storage of long-term memory 3,4. In these cascades, 
protein kinases such as Ca2+/calmodulin-dependent protein kinase II (CaMKII) 
and the cAMP-dependent protein kinase A (PKA) have a permissive role while 
protein phosphatases such as the Ca2+/calmodulin-dependent protein 
phosphatase calcineurin (CN) and protein phosphatase 1 (PP1) act as memory 
suppressors 5,6.  
 
PP1 is a ubiquitous phosphatase in the brain well positioned to orchestrate 
molecular processes resulting from neuronal activity, and is implicated in many 
brain functions. Our previous work has demonstrated that PP1 can regulate the 
expression of genes important for memory formation by influencing the 
epigenetic state of these genes, in particular, through posttranslational 
modifications of histone proteins 7-10. PP1 is also an important regulator of 
gene transcription and RNA processing 11-13.  
 
In recent years, microRNAs (miRNAs) have emerged as important regulators 
of gene expression in many biological systems. Most miRNAs identified so far 
are expressed in the brain and have distinct expression patterns at different 
developmental stages, and in different brain regions and cell types 14-16. In 
addition, many miRNAs, along with components of the miRNA biogenesis and 
silencing machinery are enriched at synaptic sites 17. So far several miRNAs 
have been implicated in neuronal functions including learning and memory 
formation 18,19. Yet, their mode of regulation in the context of cognitive 
functions remains poorly understood.  
 
Here we show that a cluster of miRNAs comprising miR-183/96/182 is 
differentially regulated upon learning and is modulated by PP1. We provide 
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evidence that the production of miR-183/96/182 precursor is favored by the 
inhibition of nuclear PP1 in a transcription-independent manner, and that 
overexpression of the cluster in the hippocampus enhances memory in adult 
mice while its knock-down impairs memory. These effects are proposed to be 
mediated by regulation of miR-183/96/182 biogenesis and suppression of 
target genes such as HDAC9.  
 
2.3. Results 
2.3.1. MiR-183/96/182 expression is increased by learning or PP1 
inhibition  
To examine the role of PP1 in the regulation of miRNAs involved in memory 
formation, we took advantage of a transgenic mouse line in which the activity 
of PP1 can be inhibited inducibly in adult forebrain neurons by expression of a 
nuclear inhibitor of PP1, NIPP1 (NIPP1*) 9. Previous work established that in 
these mice, inhibition of nuclear PP1 improves hippocampus-dependent forms 
of memory and causes widespread epigenetic and transcriptional changes of 
several genes 8-10. Based on these findings and considering that PP1 can act 
as a transcriptional and post-transcriptional gene regulator, we postulated that 
inhibition of nuclear PP1 may alter the expression of miRNAs important for 
memory formation.  
 
To test this hypothesis, NIPP1* animals and control littermates were trained on 
a novel object recognition (NOR) task, a paradigm based on the natural 
attraction of rodents for novel items that can elicit the formation of long-term 
memory (Supplementary Fig. 1). Following training, miRNAs were examined 
in the hippocampus by next generation deep sequencing. In total, over 84 
million reads were sequenced, a large proportion of which (83%) corresponded 
to a size of 19-26nt with over 92% mapping to known mouse miRNAs 
(Supplementary Fig. 2a, b). The expression level of the identified miRNAs 
varied greatly, with some miRNAs being highly abundant, and others 
moderately or weakly abundant (Supplementary Fig. 2c). Overall, the level of 
most miRNAs was consistent across samples in NIPP1* transgenic and control 
littermates whether trained or not (Supplementary Fig. 2d), suggesting no 
gross alteration of miRNAs expression by PP1 inhibition or NOR training. 
Consistently, there was no global change in the expression of major 
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components of the miRNA biogenesis machinery by PP1 inhibition 
(Supplementary Fig. 3).  
 
Differential expression analyses revealed that distinct sets of miRNAs are 
however up- or downregulated in NIPP1* mice compared to control littermates, 
and in NOR-trained mice compared to non-trained animals.  Notably, a subset 
of miRNAs was similarly altered by PP1 inhibition and training (Fig. 1a, b, 
Supplementary Fig. 4 and 5). A closer look at these miRNAs revealed that 
the miR-183/96/182 cluster is upregulated in the hippocampus in both, NIPP1* 
transgenic mice and NOR-trained controls. Quantitative PCR (qPCR) 
confirmed a consistent increase (about 50%) in miR-183 and miR-182, while 
miR-96 was expressed at low level (Fig. 1c, d). These miRNAs have been 
implicated in neuronal activity and plasticity as well as in amygdala-dependent 
fear memory 20-22, and their predicted targets are involved in plasticity and 
neuronal signaling pathways (Supplementary Fig. 15, WebGestalt analysis 
tool).  
 
To confirm the link between PP1 inhibition and upregulation of miR-183/96/182 
cluster, PP1 was knocked-down in N2A cells using a pool of siRNAs targeting 
the 3’UTR of PP1γ, an isoform predominantly linked to nuclear functions 
(Supplementary Fig. 6a). PP1γ knockdown increased the level of miR-183 
and miR-182 (Supplementary Fig. 6b), confirming that nuclear PP1 is 
implicated in the synthesis of these miRNAs. 
 
2.3.2. PP1 inhibition affects the biogenesis of miR-183/96/182 precursors 
We next examined the potential link between miR-183/96/182 cluster and PP1. 
MiRNAs are produced through a succession of biogenesis steps involving the 
transcription of primary miRNAs (pri-miRs), and their processing into precursor 
miRNAs (pre-miRs) in the nucleus then to mature miRNAs in the cytoplasm 23. 
To determine whether miR-183/96/182 biogenesis is modulated by PP1, we 
measured the level of pre-miR-183/96/182 in NIPP1* animals. In the 
hippocampus, pre-miR-183 and pre-miR-182 were up-regulated in the nuclear 
fraction and down-regulated in the cytoplasmic fraction (Fig. 2a, b). Similarly, 
neuronal activity induced by KCl treatment led to a rapid upregulation of pri-
miR-183/96/182 and corresponding pre-miR transcripts in N2A cells 
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(Supplementary Fig. 6c). Combining PP1γ  knockdown and KCl stimulation 
caused a further increase in nuclear pre-miRNAs, which was reversed by 
overexpression of a PP1γ construct carrying a siRNA-resistant open reading 
frame (Fig. 2c). Further, PP1γ knockdown reduced the level of KCl-induced 
pri-miR-183/96/182 and cytoplasmic pre-miR-183/96/182 but had no effect on 
a control miRNA (Fig. 2d, Supplementary Fig. 6d, e), suggesting the 
selectivity of the effect. We next examined whether this action of PP1 requires 
gene transcription using the transcription inhibitor actinomycin D (ActD) 
(Supplementary Fig. 7). While ActD treatment significantly reduced pri-miRNA 
transcript (Fig. 2d), it had minimal effect on the up-regulation of pre-miRs 
induced by PP1γ knockdown (Fig. 2e), suggesting that PP1γ inhibition likely 
acts downstream of RNA Pol II-dependent transcription to regulate miR-
183/96/182 level.  
 
To further explore the mechanisms with which PP1 inhibition influences the 
level of pre-miR forms of the cluster, we conducted pri-miRNA processing 
assay. In this system, cropping of the stem-loop hairpin sequence from 
artificially introduced pri-miRNA transcript correlates with reduced firefly 
luciferase signal, indicative of pri-miRNA processing 24 (Fig. 3a). We observed 
that processing of both pri-miR-183 and pri-miR-182 was significantly 
increased upon inhibition of nuclear PP1 by NIPP1 overexpression (Fig. 3b, c), 
further strengthening our prior observation. Taken together, these results 
suggest that inhibition of PP1γ facilitates the increase in miR-183/96/182 level 
triggered by neuronal activity by favoring pre-miRNA production at the 
microprocessor level.  
 
2.3.3. PP1 inhibition replenishes the existing pool of miRNAs  
Most neuronal miRNAs have a fairly rapid turnover following cellular activity, 
where changes in precursor miRNA transcription and processing precede 
changes in the level of mature miRNAs 21. To examine whether this process is 
affected by PP1, we measured the level of miR-183/96/182 transcripts at 
different time points, with and without transcriptional inhibition. We observed 
that KCl stimulation decreases the level of mature miR-183/96/182 after 30 min 
but significantly increases it after 4hr (Fig. 4a, b). The early decrease was not 
affected by ActD treatment, but the increase at 4hr was reversed and even 
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inversed (leading to a decrease) by ActD (Fig. 4c, d), suggesting an initial 
usage and depletion of miRNAs induced by activity, followed by replenishment 
through increased biogenesis. Blockade of this replenishment by ActD results 
in continued miRNAs depletion. This blockade could be partially rescued by 
PP1γ inhibition (Fig. 4e), confirming an effect of PP1 downstream of gene 
transcription.  
 
2.3.4. Modulation of miR-183/96/182 in the mouse hippocampus affects 
long-term memory 
Since the miR-183/96/182 cluster is up-regulated in the adult hippocampus 
following NOR training, we next examined whether inducing its expression at 
the time of learning has an effect on memory formation. We overexpressed 
miR-183/96/182 in hippocampus area CA1 in adult mice in vivo using a self-
complementary adeno-associated virus (scAAV) vector expressing pre-miR-
183/96/182 fused with GFP. Virus transduction and miRNA overexpression 
were confirmed by immunohistochemistry and qPCR (Supplementary Fig. 9). 
For NOR training (acquisition), the animals were exposed to three unfamiliar 
objects for 5 sessions of 5 minutes spaced by 5 minutes intervals, a protocol 
that induces robust long-term memory 7 (Supplementary Fig. 10a). MiR-
183/96/182-overexpressing mice and controls explored the objects similarly 
during acquisition (Supplementary Fig. 10b). Likewise, both groups had 
comparable long-term object memory when tested 24hr after training 
(Supplementary Fig. 10c, d). Overall locomotor activity was similar in mice 
overexpressing miR-183/96/182 and controls (Supplementary Fig. 10e, f). 
 
Previous studies on NOR and other memory paradigms have demonstrated 
that the duration and spacing of training sessions determine memory strength. 
For most paradigms, repeated and spaced training results in stronger memory 
than massed training 7,25-27. Because our training protocol was intense, it may 
have masked the effect of miR-183/96/182 overexpression. Thus, we repeated 
this and all subsequent NOR experiments using a weaker protocol based on a 
single 10-min training session, followed by two test sessions 24 hours apart 
(Fig. 5a). Overall locomotor activity of the animals during open field test or 
object exploration during training was not affected by miRNA overexpression 
(Supplementary Fig. 11a-c). During test 1, both groups had a comparable low 
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level of memory, which increased during test 2 (Supplementary Fig. 11d, e), 
consistent with the notion that retrieval helps update and strengthen memory 
28,29. Importantly, during the second test, miR-183/96/182 overexpressing mice 
had significantly better memory than control mice (Fig. 5b). To confirm the 
implication of miR-183/96/182 in long-term memory, we also expressed a 
sponge construct that competitively inhibits the miRNA cluster in the mouse 
hippocampus (Supplementary Fig. 12a, b). While sponge expression did not 
affect object exploration, it significantly impaired long-term memory 24hr after 
training (Fig. 5c and Supplementary Fig. 12 d, e). Taken together, these 
results provide evidence for the permissive role of the miR-183/96/182 cluster 
in the hippocampus in long-term object memory.  
 
2.3.5. MiR-183/96/182 cluster regulates genes involved in neuronal 
functions and regulation including HDAC9. 
Many of the predicted targets of the miR-183/96/182 cluster are involved in 
biological pathways relevant for neuronal signaling and plasticity, and 
epigenetic regulation (Supplementary Fig. 15). To validate some of these 
targets, we measured their level of expression in the hippocampus of mice 
overexpressing miR-183/96/182. Several genes including ion channels, 
receptors, a kinase, a phosphatase, and a histone deacetylase were 
significantly downregulated (Fig. 6a).  We focused on one of these genes, 
HDAC9, which codes for a member of class II HDACs known to be an 
epigenetic regulator modulated by neuronal activity, and involved in the control 
of plasticity-related genes (Lang et al 2012, Lucio-Eterovic et al 2008, Mejat et 
al 2005, Sugo et al 2010). Histone acetylation and the enzymes that modulate 
acetylation such as HDACs, play a crucial role in the formation and storage of 
long-term memory 30 and HDAC inhibitors are increasingly appreciated as 
potential treatment options for cognitive deficits 31. We therefore explored the 
link between the miR-183/96/182 cluster and HDAC9. We examined if HDAC9 
is a direct target of miR-183/96/182 using a luciferase-based expression 
system containing a predicted miR-182 binding site of HDAC9 3’UTR. Upon 
miR-182 transfection, we observed destabilization of the construct, indicating 
targeting of the predicted HDAC9 target site by miR-182  (Fig. 6b). Further, the 
level of HDAC9 was reduced in the hippocampus of mice subjected to NOR 
training and testing compared to controls (Fig. 6c). To further evaluate the 
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importance of HDAC9 targeting by miR-183/96/182, we interfered with miR-
182/HDAC9 interaction in vivo by injecting LNA modified target site blockers 
(TSB) (Supplementary Fig. 14). Interfering with miR-182 targeting of HDAC9 
in mice overexpressing miR-183/96/182 cluster significantly reduced object 
exploration behavior during training and testing, without affecting novel object 
discrimination (Fig. 7 c-e). Together, these results identify HDAC9 as one of 
the mediating factors of miR-182/96/183 on cognitive processes.  
 
2.4. Discussion 
Our results newly reveal a novel role for the memory suppressor PP1 in the 
biogenesis of miRNAs during memory formation. They show that PP1 inhibition 
increases the level of the miR-183/96/182 cluster, and identify this cluster as 
an important modulator of memory formation. PP1 inhibition acts by enhancing 
the production of pre-miRNAs in the nucleus. This occurs in a background of 
mature miR-183/96/182 consumption upon neuronal stimulation and continued 
replenishment by increased transcription. These findings suggest that PP1 
inhibition facilitates nuclear miRNA processing during neuronal activity, 
possibly by influencing the microprocessor complex.  
 
Several studies have reported the involvement of protein phosphorylation in 
pri-miRNA processing, mainly through protein kinase-mediated regulation of 
the stability, interaction, and nuclear localization of components of the 
microprocessor complex 32,33 34,35. This study significantly extends these 
findings by newly showing that PP1 is involved in this processing. The precise 
modes of action of PP1 remain unknown but PP1 may modulate the 
processing of specific miRNAs by interacting with RNA binding proteins that 
contain a PP1 recognition motif 36. It could also act on splicing since it can 
interact with components of the spliceosome machinery, which is known to 
crosstalk with nuclear miRNA processing 37-40. Binding of proteins such as 
Tra2-beta1, SF2A, Srp30c, and ASF to PP1 through conserved RNA 
recognizing domains is essential for correct splice site selection 36,41 and may 
thus by extension, also affect miRNA processing.  Interestingly, a recent study 
demonstrated a developmentally-timed processing of pri-miR-183/96/182 that 
is crucial for neuronal organization. This is mediated through its interaction with 
a component of the microprocessor complex – Ddx3x 42. Our results further 
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corroborate the highly regulated processing that this cluster undergoes in 
neurons in response to external signals.  
 
The present results further show that overexpression of miR-183/96/182 in the 
mouse hippocampus improves long-term object memory. Interestingly, this 
effect is observed following training with a weak (single session), but not a 
strong (spaced sessions) training protocol. This could be attributed to a 
‘spacing effect’ where sessions separated over a period of time lead to 
stronger activation of molecular pathways needed for memory formation, 
including plasticity-related proteins 26. Further, miRNA manipulations often 
produce modest changes in gene expression and hardly detectable phenotype 
in normal physiological conditions, but which become apparent in suboptimal 
conditions 43,44. 
 
Our finding that miR-183/96/182 overexpression improves memory does not 
conform with a previous report showing that miR-182 is reduced in the lateral 
amygdala after auditory fear conditioning, and its overexpression impairs long-
term auditory fear memory 20. The reason for these different results is unknown 
but it could be that miR-183/96/182 or miR-182 in the cluster is differently 
regulated in different brain areas, and/or acts on different targets.  
 
The present results are also highly relevant to neuropsychiatric disorders since 
both HDAC9 and miR-182 have been implicated in schizophrenia. HDAC9 is 
one of a few genes with rare copy number variation in schizophrenia patients 45 
and a hemizygous deletion in a small proportion of patients 46. Further, 
disrupted hippocampal miR-182 signaling has been linked to changes in gene 
expression observed in schizophrenia and other mental illnesses 47. A single 
nucleotide polymorphism in this miRNA is predicted to be among key SNPs 
linked to the disease 48.  
 
Finally, the present results have implications for the epigenetic roles of PP1. 
PP1 is known to influence histone acetylation by direct association with HDACs 
9,49 or by crosstalks with some chromatin targets that affect HDACs 50. Our 
results suggest another indirect control of HDACs by PP1 involving miRNAs. 
Interestingly, inhibiting HDACs induces substantial upregulation of miR-
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183/96/182 cluster in neuroblastoma cell lines 51, suggesting a possible 
feedback regulatory loop between HDACs and miRNAs .  
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2.5. Materials and methods 
Animals 
To inhibit nuclear PP1 in the mouse hippocampus, transgenic mice carrying 
the PP1 binding domain of the nuclear inhibitor of PP1, NIPP1 (NIPP1*) fused 
to EGFP (NIPP1*-EGFP6) and placed under a tetO promoter, were crossed 
with mice expressing a reverse tetracycline-controlled transactivator 2 (rtTA2) 
under the control of a CaMKIIalpha promoter 9. Conditional expression of 
NIPP1* in double transgenic mice was achieved by feeding the animals with a 
diet containing doxycycline (Pelodis®) for 8 days (6mg/g of wet mouse chow). 
The mice were group-housed (4 mice per cage) under a reverse 12h light/dark 
cycle (25oC, 55% humidity), with food and water ad libitum. Behavioral 
experiments were carried out on rtTA2/NIPP1*-EGFP6 adult male and control 
littermates (3-5 month old) of C57Bl/6 mice background, during the animals’ 
dark cycle. All experiments were conducted by experimenters blind to 
genotype. Experiments and animal maintenance were conducted in 
compliance with the Federation of Swiss Cantonal Veterinary Office and 
approved by Zürich Cantonal Veterinary Office (54/2012).  
 
Object recognition task 
Object recognition training was conducted in a rectangular arena 
(60cmx50cmx45cm), with gray, opaque walls and translucent plexiglass 
bottom, under which an infrared light source was placed. It was located in a 
dedicated behavioral room illuminated by a dim light. Before NOR training, 
each animal was handled daily for 4 minutes on 4 consecutive days. Then an 
open field test was conducted by placing each mouse in an empty arena for 10 
minutes and measuring the overall locomotion activity. An additional 
habituation to the empty arena was conducted one day later, before training 
started. For training (acquisition), three different unfamiliar objects were placed 
in the center of the arena in a triangular arrangement. Each animal was 
allowed to explore the objects for five 5-min sessions spaced by a 5-min 
interval (strong protocol), or a single 10-min session (weak protocol). Object 
memory was tested in a 5-min session for which one of the familiar objects was 
replaced with a novel object. For the strong protocol, object memory was 
tested 24hr after training, and for the weak protocol, memory was tested 24hr 
(test1) and 48hr (test2) after training. The time that an animal spent exploring 
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each object during testing was measured manually and with a video tracking 
system (ViewPoint Behavior Technology) by an experimenter blind to group 
assignment. Object memory was expressed as the proportion of time spent 
exploring the novel object compared to the time spent exploring all objects 
(discrimination ratio). The discrimination ratio was normalized taking the 
average value from control animals as 100%. Throughout all experiments, 
movement of each animal inside the arena was tracked by an infrared camera 
connected to a tracking software (ViewPoint Behavior Technology) in an 
adjacent room. For miRNA expression experiments, NOR controls (identified 
as ‘habituation only’ or ‘non-trained’ groups) were subjected to identical 
procedures but with no exposure to objects. 
 
Virus vector design and production 
Plasmids for miRNA overexpression and sponge. The scAAV2-EF1a-pri-
miR-183/96/182-GFP construct was produced by cutting scAAV2-MCS (Cell 
Biolabs) by BalI/NotI (New England Biolabs). The transgene cassette 
containing Ef1a promoter (sequence from pEGP-mmu-miR-182 plasmid; Cell 
Biolabs), engineered truncated (T)-pri-miR-183/96/182, EGFP (from pEGP-
mmu-miR-182 plasmid; Cell Biolabs), WPRE motif and 5’-BalI and 3’-NotI 
adapters was chemically synthesized by GENEWIZ (South Plainfield, USA) 
and cloned into the scAAV backbone. Sequence of T-pri-miR-183/96/182 was 
as follows with mature miRNAs 
underlined:5’cctctgcagggtctgcaggctggagagtgtgactcctgtcctgtgtatggcactggtagaatt
cactgtgaacagtctcagtcagtgaattaccgaagggccataaacagagcagagacagatccgcgagca
ccttggagctcctcacccctttctgcctagacctctgtttccaggggtgccagggtacaaagacctcctctgctc
cttccccagagggcctgttccagtaccatctgcttggccgattttggcactagcacatttttgcttgtgtctctccgct
gtgagcaatcatgtgtagtgccaatatgggaaaagcgggctgctgcggccacgttcacctcccccggcatcc
cataataaaaacaagtatgctggaggcctcccaccatttttggcaatggtagaactcacaccggtaaggtaat
gggacccggtggttctagacttgccaactatggtgtaagtgctgagct. The scAAV2-EF1a-pri-
miR-183/96/182-GFP allowed the generation of mature miR-183-5p, miR-96-
5p, and miR-182-5p sequences annotated in miRBASE v.20 
(www.mirbase.org), whose expression was verified both by RT-qPCR and 
Northern blot analysis in HEK293 cells transfected with scAAV2-EF1a-pri-miR-
183/96/182-GFP plasmid (data not shown). We also verified that expression of 
these miRNAs in HEK293 cells leads to specific repression of reporter mRNAs 
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bearing miR-183/96/182 sites (data not shown). Control scAAV2-EF1a-control-
GFP construct contained fragment of beta-globin intron (sequence from pEGP-
mmu-miR-182 plasmid; Cell Biolabs) of length corresponding to T-pri-miR-
183/96/182.  
 
To suppress the level of endogenous miRNAs, a triple sponge for the miR-
183/96/182 cluster containing 4 binding sites for each miRNA (perfectly 
complementary and containing a bulge) separated by a 15nt spacer sequence 
were prepared as described previously 21. The sponge sequences were 
assembled in pJ341 plasmids, excised at Hind III sites, and cloned into a p56 
plasmid upstream of EGFP ORG. Sequence integrity was verified with 
sequencing.  
 
scAAV production. Self-complementary AAV production was performed by 
triple transfection of HEK 293T cells using polyethylenimine with a plasmid 
bearing the target sequences between the internal terminal repeats of scAAV2, 
the AAV-helper plasmid encoding Rep2 and Cap for serotype 8, and the 
pHGTI-Adeno1 plasmid harboring helper adenoviral genes (both kindly 
provided by C Cepko, Harvard Medical School, Boston, MA, USA). Vectors 
were purified using a discontinuous iodixanol gradient (Sigma, Optiprep). 
Encapsidated DNA was quantified by TaqMan RT-PCR following denaturation 
of the AAV particles by Proteinase K, and titers were calculated as genome 
copies (GC) per ml. 
 
Stereotaxic surgery and intrahippocampal injection 
To overexpress or inhibit miRNAs, virus vectors were prepared as described 
above. To interfere with miR-182-HDAC9 binding, custom designed miRCURY 
LNATM microRNA Power Target Site Blockers were obtained from Exiqon. The 
sequences are: miR-182/HDAC9 TSB: TTTGGCAAAAGTGCTA; negative 
control TSB: ACGTCTATACGCCCA. The oligonucleotides were stereotaxically 
injected in to the CA1 region of the hippocampus at a concentration of 1ug/ul, 
in TurboFect in vivo transfection reagent (Dharmacon). To carry out injections, 
animals were anaesthetized with 3% isofluorane (Attane™) and placed in a 
stereotaxic frame. Anesthesia was maintained with 1.5% isofluorane in 100% 
oxygen for throughout surgery. Injection was carried out by lowering a glass 
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pipette (Blaubrand®, cut to a 20um inner diameter) filled with 
virus/oligonucleotides and attached to an injection pump (Stoelting) through a 
predrilled hole at the following coordinate targeting CA1 region of the 
hippocampus (from Bregma): AP: -2.0mm, ML: +/- 1.5mm, DV: -1.6mm. A total 
of 1ul (109GC/ml) of virus vector or 1.5ul of TSB oligos was injected into each 
hippocampus at a rate of 0.2ul/min. The glass pipette was left in place for an 
additional 5 minutes, before it was carefully withdrawn and the wound was 
closed. The animals were allowed to recover for up to 2 weeks in their home 
cage before behavioral testing.  
  
Cell culture 
Mouse neuroblastoma (N2A) cells were obtained from American Type Cell 
Culture Collection (ATCC) and cultured in Dulbecco’s Modified Eagle’s Medium 
(DMEM- high glucose), supplemented with 10%(v/v) FBS (Gibco®) and 1% 
Antibiotic-Antimycotic (Gibco ®). These cells were chosen for their fast-growth, 
easy maintenance and transfection, and potential for neuronal differentiation 
making them a convenient model for studying miRNA biogenesis. The cells 
were proven free of mycoplasma contamination through regular tests. Before 
the start of experiments, the cells were passaged 1:4 and split every 3 days for 
at least 5 passages. On transfection day, 150,000 - 300,000 cells were plated 
in 6-well plates. Transfection of a pool of siRNAs targeting PP1γ 3’UTR 
(ThermoFischer Scientific, sequences in supplementary material) or negative 
control siRNA (All Star negative control, Qiagen) was carried out with 
HiPerfect® transfection reagent (Qiagen). In pri-miRNA processing assays, 
inhibition of nuclear PP1 was achieved by overexpression of a plasmid 
containing NIPP1 construct (Origene). Then the cells were returned to the 
incubator and allowed to grow for 72 hours prior to harvest or further treatment. 
In KCl treatment conditions, 50mM of KCl was added to plated cells 1hr before 
harvest (unless indicated otherwise). In actinomycin D (Tocris®) treatment 
conditions, the cells were treated with 5mg/ml of the drug prepared in DMSO 
1hr before KCl treatment or harvest.  Rescue of PP1γ knockdown effects was 
performed by co-transfecting a plasmid containing PP1γ open reading frame 
(Origene) with siRNA against PP1γ 3’UTR. The cells were harvested by 
removing the medium, washing with ice-cold PBS 3 times, and lysing with Tri-
reagent® (for RNA extraction) or RIPA buffer (for protein extraction). All 
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experiments were conducted on at least three replicates from different passage 
number, and repeated at least three times.  
 
Luciferase-based pri-miRNA processing and HDAC9 target validation 
assays 
Pri-miRNA processing assays were conducted as previously described 24. The 
assay quantifies Drosha processing of pri-miRNA based on the decrease in 
luciferase activity, which is inversely proportional to the Drosha processing of 
pri-miRNA.  Briefly, fragments of pri-mir-182 and pri-mir-183 containing the 
hairpin and 100 bp flanking sequence were amplified from genomic DNA. The 
PCR products were digested with the respective restriction enzymes and 
inserted at MCS in pmirGLO vector (Dual Reporter Luciferase Assay System, 
Promega) downstream to firefly luciferase reporter. Cropping of the hairpin 
stem-loop of the inserts result in destabilization of the firefly reporter resulting 
in decrease in firefly luminescence. The unperturbed Renilla reporter produces 
stable luminescence, which serves as internal normalization control. Dual-
luciferase reporters with pri-mir-182, and pri-mir-183 were transfected in N2a 
cells using cationic liposomes (Lipofectamine 2000 reagent, Invitrogen). PP1 
manipulations were performed by simultaneously transfecting N2a cells with 
NIPP1 over-expressing plasmid (Origene). The cells were lysed 48 hr post-
transfection with passive lysis buffer (Promega) treatment at room temperature 
for 10 minutes. The lysates were then transferred to a 96 well plate, and 
luciferase activities of firefly and Renilla were read through luminometer 
GloMax 96 (Promega) equipped with dual injections dispersing LAR II (for 
firefly luciferase quantification) and Glomax (for renilla luciferase quantification) 
reagents sequentially.    
 
For validation of HDAC9 targeting by miR-182, the same vector system and 
cloning strategy as described above was used (with the exception that HDAC9 
3’UTR sequence containing miR-182 target site was amplified from genomic 
DNA using the following primers and inserted into the vector: hdac9_F1_NheI-
GGCATAgctagcAGGATATGTGCCAGGCAGTC, hdac9_R1_SaII-
CGCTTAgtcgacAATGGGCGTCATTGTTCTTC). Dual-reporter vectors with 
3’UTR HDAC9 inserts were transfected in N2a cells using cationic liposomes 
(Lipfectamine 2000 reagent, Invitrogen). MiR-182 mimic (Qiagen) was 
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simultaneously transfected to the cells. The cells were lysed 24 hr post-
transfection with passive lysis buffer (Promega) treatment at RT for 10 
minutes. The lysates were then transferred to a 96-well plate, and luciferase 
activity of firefly and Renilla were read through luminometer GloMax 96 
(Promega) equipped with dual injections dispersing LAR II (for firefly luciferase 
quantification) and Glomax (for renilla luciferase quantification) reagents 
sequentially.    
 
RNA extraction and RT-qPCR 
Mouse hippocampal tissue was homogenized using TissueLyser (Qiagen) in 
Trizol® reagent (Invitrogen). Total RNA was extracted by phenol-chloroform 
precipitation. For extraction from cells, the medium was removed, the cells 
were washed three times with ice cold-PBS, lysed and homogenized by adding 
Trizol® to the plates. Subcellular fractionation of nuclear and cytoplasmic RNA 
was performed using Norgen’s Cytoplasmic and nuclear RNA purification kit 
(Norge BioTek, Canada). One microgram of total RNA was treated with RNase 
free DNase (Promega) and reverse transcribed using miScript II RT kit® 
(Qiagen). Miscript primer assays for mature and precursor miRNAs were used 
to amplify the respective transcripts from a cDNA pool (Supplementary Table 
1). For mRNA quantification, custom designed gene specific primers were 
used (Supplementary Table 1). Real time PCR was performed on LightCycler 
480® (Roche). Small nuclear RNA (RNU6) or GAPDH was used as 
endogenous control and quantification was performed as previously 52.  
 
Deep sequencing 
The quality and quantity of RNA was determined using a Bioanalyzer® 
(Agilent) and Qubit® fluorometer (Invitrogen) respectively. Small RNA libraries 
were prepared from 1ug of total RNA using TruSeq® Small RNA Kit (Illumina) 
according to manufacturer’s instructions. Briefly, 3’ and 5’ adapters were 
ligated to small RNAs using T4 DNA ligase. Ligated RNA was reverse 
transcribed to cDNA using superscript II reverse transcriptase. The resulting 
cDNA template was amplified by PCR to generate a cDNA library. For each 
sample, a common forward primer (which binds to the 5’ adapter complement) 
and a unique reverse primer (which binds to the 3’ adapter complement and 
contains a unique sequence for each sample) were used.  The quality of the 
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resulting amplicons was analyzed on a high sensitivity DNA ChIP 
(Bioanalyzer). Next, the cDNA construct was run on a 6% PAGE gel and 
amplicons corresponding to adapter ligated miRNA sequences (145-160nt) 
were excised out. DNA from excised gel was eluted and precipitated in 
Ethanol. The size, purity, and amount of cDNA was assessed on high 
sensitivity DNA ChIP (Bioanalzyer).  Then a titration run was done to check 
quality of the library and validate the amount. Finally, multiplexed samples 
were sequenced on Hi-Seq 2000 using TrueSeq™ SBM v5 sequencing kit. 
The resulting sequences were demultiplexed and sorted to individual samples 
according to their index codes. The error rate for each library was estimated 
based on a PhiX reference spiked before sequencing. Next, adapters were 
trimmed from the reads and the resulting inserts were categorized by size. 
Bioinformatic analysis of sequencing reads was performed using ncPRO-seq 
pipeline 53. After confirming that the majority of reads are attributed to the size 
range of miRNAs, the sequences were mapped and aligned to the mouse 
reference genome (NCBI37/mm9) using bowtie algorithm. The number of 
reads uniquely mapping to miRNAs were normalized to the total number of 
reads in each sample. Finally, differential expression analysis of miRNAs 
regulated upon expression of NIPP1* and/or during memory formation was 
performed using Wilcoxon unpaired test 54.  
 
Protein extraction and Western blot 
Total protein was extracted from N2A cells using radio immunoprecipitation 
buffer (RIPA) with 1:1000 protease inhibitor cocktail (Sigma-Aldrich) and 1:500 
phenyl methyl sulfonyl fluoride (PMSF). Cells were lysed directly on the culture 
plate with 100-150 ul RIPA and scraped off with a cell scraper. The lysate was 
transferred to a micro centrifuge tube and sonicated for 5 cycles, each 
comprising 30 seconds of sonication with 30 seconds intervals. The resulting 
mixture was centrifuged for 15 minutes at 14,000g to separate the protein 
mixture (supernatant) from cellular debris (pellet). 20-40 ug proteins were 
resolved on SDS-PAGE and transferred onto a nitrocellulose membrane (Bio-
rad). Membranes were blocked in 3% BSA for one hour, and then incubated in 
primary (overnight at 4oC) and secondary (one hour at room temperature) 
antibodies. They were scanned using Odessey IR scanner (Li-Cor Bioscience), 
and band intensity was determined and quantified using image analysis 
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software (ImageJ). The following antibodies were used: primary – HDAC9 
(Abcam, ab59718), PP1γ (Millipore, 07-1218); secondary – anti-mouse 
IRDye® goat anti-mouse (LI-COR, 925-32210) and IRDye® goat anti-rabbit 
(LI-COR, 925-32211). 
 
Statistical analyses 
For deep-sequencing data, differential expression between two groups was 
assessed by Wilcoxon signed-rank test. For miRNA and mRNA qPCRs and 
behavioral experiments with two groups, two-tailed Student t test was used to 
assess statistical significance. For other qPCR experiments with more than 2 
groups, ANOVA was used. Tukey’s or least significant difference (LSD) post 
hoc analyses were conducted when appropriate. Outliers were defined as 
values beyond two standard deviation from a group mean and were removed 
from the analysis. Significance was set at p ≤ 0.05 for all tests and two-sided 
tests were performed. Statistical analysis was performed using GraphPad 
prism or R statistical software. 
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2.9. Supplementary Figures & Table 
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3.1. Abstract 
Molecular mechanisms underlying age-related cognitive decline (ARCD) 
remain largely unknown. We show that aging-induced increase in the nuclear 
activity of memory inhibitor protein phosphatase 1 (PP1) in the hippocampus 
neurons causes ARCD by impairing the microprocessor-mediated biogenesis 
of microRNA (miR) cluster, miR-183/96/182. Dysregulated PP1-dependent 
biogenesis of miR-183/96/182 may also contribute to the non-genomic 
blockade on cognitive functions in neurodegenerative disorders characterized 
by TDP-43 loss of function.  
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3.2. Main Body 
Aging is associated with progressive deterioration of learning and memory 
formation termed as age-related cognitive decline (ARCD).1 The molecular 
mechanisms underlying ARCD are largely unknown, but may involve protein 
phosphatase 1 (PP1) and Calcineurin (CaN), which are negative regulators of 
memory.2,3 We previously showed that PP1 regulates the nuclear biogenesis of 
memory-promoting microRNAs (miRs), miR-183/96/182, in a transcription-
independent manner.4 Here, we show that increase in nuclear PP1 by aging 
selectively impairs the microprocessor processing of miR-183/96/182 by 
modulating the receptor SMAD (R-SMAD) dependent regulation of the 
microprocessor. We further show that a similar mechanism may contribute to 
the cognitive dysfunction in TDP-43 proteinopathies (CD TDP), and that 
artificial over-expression of miR-183/96/182 rescues ARCD.    
 
Using a weak protocol of novel object recognition (NOR) training 
(Supplementary Fig. 1), we showed that aged (20-21 months old) mice 
perform worse than young (4-5 months old) mice when tested for their object 
recognition memory 24 and 48 hours post-training (Fig. 1a). We then 
quantified miR-183 and miR-182 in hippocampal tissue extracted from young 
and aged mice 30 minutes after NOR training. NOR training increased 
hippocampal miR-183 and 182 (Fig. 1b), as well as, pre-mir-182 and pri-mir-
183-96-182 in young mice (Fig. 1c). However, aging prevented the NOR 
training-induced increase of hippocampal miR-183 and 182 at the precursor 
(Fig. 1c) and mature level (Fig. 1b). As PP1 regulates the post-transcriptional 
biogenesis of miR-183/96/182, we next investigated if suppression of miR-
183/182 up regulation upon NOR training with aging was due to increased 
nuclear PP1. Indeed, hippocampal tissue from aged mice showed increased 
nuclear PP1 activity (Fig. 1d). This was accompanied by a decreased 
expression of PP1 inhibitory subunit PP1R1A, and increased expression of 
PP1 nuclear localization partner AKAP1, as well as, another phosphatase 
PPP2CA (Supplementary Fig. 2).  
 
To show that microprocessor processing of pri-mir-183/96/182 is impaired by 
aging-induced increased in nuclear PP1, we conducted pri-mir-183 and 182 
processing assays in mouse neuroblastoma (N2a) cells. This assays employs 
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renilla-luciferase dual-reporter system, in which cropping of the stem-loop 
sequence of the artificially introduced pri-mir-sequence reduces firefly signal, 
indicating microprocessor processing.4,5 Induction of senescence in N2a cells 
by hydroxyura treatment6 (Supplementary Fig. 3), as well as, over-expression 
of PP1 decreased the microprocessor processing of pri-mir-183/96 
(Supplementary Fig. 4). To understand how PP1 regulates the 
microprocessor processing of pri-mir-183/96/182, we looked at the expression 
of major components of the microprocessor complex after PP1 manipulation in 
N2a cells. Over-expression of PP1 or its nuclear inhibitor (NIPP1) in N2a cells 
did not alter nuclear protein expression of Drosha/DGCR8 (Supplementary 
Fig. 5). Further, we could not detect a direct interaction of PP1 with the 
microprocessor in Drosha co-IP experiments (Supplementary Fig. 6: data not 
shown), suggesting involvement of an intermediate. R-SMAD proteins are 
down-stream signal transducers of transforming growth factor-beta (TGF-beta) 
and bone-morphogenic protein (BMP) that regulate the biogenesis of certain 
microRNAs by interacting with the SMAD binding element (SBE) on their 
primary transcripts, as well as, the microprocessor component p68.7,8 Over-
expression of NIPP1 in N2a cells increases the phosphorylation of SMAD1/5 at 
Serine 463/465 required for their nuclear localization and interaction with p-68 
(Supplementary Fig. 7).7 These results suggest that aging-induced increase 
in nuclear PP1 can decrease the microprocessor processing of miR-
183/96/182. Indeed, hippocampal expression of miR-21, previously shown to 
be regulated post-transcriptionally by R-SMADs is altered by PP1 manipulation 
in N2a cells (Supplementary Fig. 8). On the other hand, microprocessor 
processing of pri-mir-183, but not of a control miRNA (pri-mir-10b), showed 
dependence on R-SMAD signaling (Supplementary Fig. 9).    
 
We next attempted to reverse ARCD in aged mice. For this, we overexpressed 
miR-183/96/182 in hippocampus area CA1 using a self-complementary adeno-
associated virus (scAAV) vector expressing pre-miR-183/96/182 fused with 
GFP. Virus transduction and miRNA overexpression were confirmed by 
immunohistochemistry and qPCR (Supplementary Fig. 10 data not shown). 
Importantly, aged mice with hippocampal over-expression of miR-183/96/182 
performed comparable to young mice when tested for their object recognition 
memory at both 24 and 48 hours after NOR training (Fig. 1e). This result 
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reiterates the previously shown role of miR-183/96/182 in long-term memory, 
and highlights their potential to correct ARCD.4 To further validate the 
implication of PP1-miR-183/96/182 pathway in ARCD, we measured nuclear 
PP1 activity in hippocampal tissue from aged mice, which were exposed to 
environment enrichment (EE) for four weeks (Supplementary Fig. 11: data 
not shown). EE, which is known to rescue ARCD,1,9 decreased nuclear PP1 
activity (Fig. 1f) by increasing the expression of PP1 inhibitory subunits 
PP1R1A and NIPP1 (Fig. 1g). Further, decrease in PP1 nuclear activity with 
EE also lead to an increase in miR-183/182, as well as, their precursors 
(Supplementary Fig. 12).   
 
Emerging evidence suggests that changes in miRNAs expression and 
functioning impair memory in neurodegenerative disorders.10 miRNA-mediated 
pathways may arbitrate cognitive dysfunction in these disorders both by 
promoting neuronal death and through changes in memory relevant gene 
expression, especially in cases of early and subtle impairments in memory 
preceding neuronal death.10-12 Furthermore, it has been recently shown that 
increased activity of histone deacetylases (HDACs) induces an epigenetic 
blockade on memory formation in the neurodegenerating brain.13 To check if 
increase in nuclear PP1 and resulting decrease in biogenesis of miR-
183/96/182, which target HDAC9,4 could contribute to such non-genomic 
blockade of memory, we performed pri-mir-183/182 assays under different loss 
of nuclear function conditions simulating neurodegenerative disorders in vitro; 
α-synuclein knock down (Parkinson disease), and TDP-43/ FUS knock-downs 
(amyotrophic lateral sclerosis/ frontotemporal lobar degenertaion) 
(Supplementary Fig. 13: data not shown). TDP-43 knock down impaired 
microprocessor processing for both pri-mir-183 and pri-mir-182 (Fig. 2a) that 
could be rescued in case of pri-mir-183 by pharmacological inhibition of PP1 
(Supplementary Fig. 14), suggesting that the decrease in microprocessor 
processing of miR-183/96/182 on TDP-43 loss of function involves PP1. 
Indeed, knock down of TDP-43 lead to an increase in nuclear PP1 activity in 
N2a cells (Fig. 2b) without changing the expression of Drosha or DGCR8 
(Supplementary Fig. 15). We further analyzed the expression of miR-
183/96/182 in frontal cortex tissue from patients with amyotrophic lateral 
sclerosis (ALS), a neurodegenerative condition characterized by TDP-43 
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pathology (Supplementary Fig. 16: data not shown) and cognitive 
dysfunction in almost 50% of the patients.14,15 miR-183/96/182 and their 
precursors (Supplementary Fig. 17: data not shown) were decreased in ALS 
(Fig. 2c), with a corresponding increase in the expression of their targets (Fig. 
2d), and PP1γ, the predominantly nuclear isoform of PP1 (Fig. 2e).  
 
Taken together, our findings identify impaired microprocessor processing of 
miR-183/96/182 resulting from increased nuclear PP1 as an important 
pathogenic mechanism underlying ARCD and CD TDP. This memory 
impairment pathway involves R-SMADs as potential intermediates, and is 
amenable to therapies targeted at decreasing neuronal nuclear PP1 and/or 
artificially increasing miR-183/96/182 in the hippocampus (Fig. 2f).   
 
3.3. Materials & Methods 
Animals 
Young (3-4 months old) and aged (>18 months old) C57Bl/6 mice were 
purchased from Janvier (France). The mice were group-housed (4 mice per 
cage) under a reverse 12h light/dark cycle (25oC, 55% humidity), with food and 
water ad libitum. Behavioral experiments were carried during the animals’ dark 
cycle. Experiments and animal maintenance were conducted in compliance 
with the Federation of Swiss Cantonal Veterinary Office and approved by 
Zürich Cantonal Veterinary Office (54/2012).  
 
Novel object recognition (NOR) task 
Object recognition training was conducted in a rectangular arena 
(60cmx50cmx45cm), with gray, opaque walls and translucent plexiglass 
bottom, under which an infrared light source was placed. It was located in a 
dedicated behavioral room illuminated by a dim light. Before NOR training, 
each animal was handled daily for 4 minutes on 4 consecutive days. This was 
followed by an open field test, which involved placing each mouse in the empty 
arena for 10 minutes and measuring their overall locomotion activity. An 
additional habituation to the empty arena was conducted one day before the 
NOR training. For training (acquisition), three different unfamiliar objects were 
placed in the center of the arena in a triangular arrangement. Each animal was 
allowed to explore the objects for a single 10-min session. Object memory was 
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tested in 5-min sessions for which one of the familiar objects was replaced with 
a novel object at 24h (test1) and 48h (test2) after training. The time that an 
animal spent exploring each object during testing was measured with a video 
tracking system (ViewPoint Behavior Technology) by an experimenter blinded 
to group assignment. Object memory was expressed as the proportion of time 
spent exploring the novel object compared to the time spent exploring all 
objects (discrimination index). The discrimination index was normalized taking 
the average value from control animals as 100%. The animal movements were 
tracked by an infrared camera connected to a tracking software (View Point 
Behavior Technology). For miRNA expression experiments, NOR controls 
(identified as ‘habituation’) were subjected to identical procedures without an 
exposure to objects. 	  
Environment enrichment (EE) 
Aged (19-21 months) and young adult (4-5 months) C57Bl/6J male mice were 
either housed in standard cages or in environmentally enriched cages for 4 
weeks. Standard housing consisted of a clear polycarbonate standard Aero 
cages (391 x 199 x 160 mm) containing wood chip bedding and nesting 
material. Enriched housing consisted of a clear polycarbonate type 2000P 
cage (610 x 435 x 215 mm) containing wood chip bedding, nesting material, 
two running wheels, a climbing ladder, a jungle gym, a plumbing pipe, multiple 
plastic balls, a rubber ball and a wooden stick.  
 
Cell culture 
Mouse neuroblastoma (N2A) cells were obtained from American Type Cell 
Culture Collection (ATCC) and cultured in Dulbecco’s Modified Eagle’s Medium 
(DMEM- high glucose), supplemented with 10%(v/v) FBS (Gibco®) and 1% 
Antibiotic-Antimycotic (Gibco®). These cells were chosen for their fast-growth, 
easy maintenance and transfection, and potential for neuronal differentiation 
making them a convenient model for studying miRNA biogenesis. The cells 
were proven free of mycoplasma contamination through regular tests. Before 
the start of experiments, the cells were passaged 1:4 and split every 3 days for 
at least 5 passages. On transfection day, 150,000 - 300,000 cells were plated 
in 6 or 12-well plates. Transfection of a pool of siRNAs targeting TDP-
43/FUS/α-synuclein (Flexitube siRNA, Qiagen) or negative control siRNA (All 
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Star negative control, Qiagen) was carried out with HiPerfect® transfection 
reagent (Qiagen). Inhibition and over-expression of nuclear PP1 was achieved 
by overexpression of plasmids containing NIPP1 and PP1γ open read frame 
constructs respectively (Origene). Then the cells were returned to the incubator 
and allowed to grow for 48 hours prior to harvest or further treatment. The cells 
were harvested by removing the medium, washing with ice-cold PBS three 
times, and lysing with Tri-reagent® (for RNA extraction) or RIPA buffer (for 
protein extraction) or 0.05% Trypsin-EDTA (for sub-cellular fractionation). All 
experiments were conducted on at least three replicates from different passage 
number, and repeated at least three times.  
	  
Drug Treatments 
Cellular senescence was induced by treating N2a cells with 8 or 16mM 
hydroxyurea (HU, Sigma-Aldrich, St. Louis, MO, USA) for an incubation time 
(37°C, 5% CO2) of 12 h. HU treatment was done 12 h prior to cell lysis. H2O 
was used as a control. Induction of cellular senescence was confirmed by 
checking the expression of senescence markers p21 and p53. Primer 
sequences: p21 (Fwd: TACTTCCTCTGCCCTGCTGC, Rev: 
GCTGGTCTGCCTCCGTTTT), p53 (Fwd: CACGTACTCTCCTCCCCTCAAT, 
Rev: AACTGCACAGGGCACGTCTT). Protein phosphatases were inhibited by 
treating N2a cells with Okadaic acid (Cell Sigaling) at two different doses; 20 
nM (inhibition of PP1/PP2A), and 0.1 nM (inhibition of PP2A only).16  
 
Nuclear PP1 activity assay 
Nuclear PP1 activity assay was performed as previously described.17 Briefly; 
hippocampi were dissected and homogenized in 500 ul of cytoplasmic 
extraction buffer (Subcellular Protein Fractionation Kit for Tissue, Thermo 
Fischer scientific), transferred to Pierce Tissue Strainer and centrifuged at 
500g for 5 minute. The supernatant containing the cytoplasmic protein fraction 
was isolated, and the pellet containing the nuclear fraction was incubated on 
ice for 10 minutes, and centrifuged at 3000g for 5 minues in 325 ul membrane 
extraction buffer. The pellet containing the nuclei was resuspended in 110 ul of 
nuclear extraction buffer (NEB), incubated for 30 minutes, and centrifuged at 
5000g for 5 minutes. The supernatant containing soluble nuclear extracts was 
desalted using PiBind resin (Innova Biosciences). Phosphatase activity was 
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determined by incubating 20 ul of the isolated nuclear fraction with 0.75 mM RII 
phosphopeptide substrate (BIOMOL), with or without 5nM Tautomycin 
(selective inhibitor of PP1 at 5 nM, ENZO Life Sciences) at 30oC for 10 
minutes. The amount of free phosphate released was measured with BIOMOL 
green reagent (BIOMOL) at 620 nm and background subtracted. Nuclear PP1 
activity was calculated by subtracting the nuclear phosphatase activity with 
Tautomycin from the nuclear phosphatase activity without Tautomycin.  
 
Luciferase-based pri-miRNA processing  
Pri-miRNA processing assays were conducted as previously described.4,5 
Briefly, fragments of pri-mir-182 and pri-mir-183 containing the hairpin and 100 
bp flanking sequence were amplified from genomic DNA. The PCR products 
were digested with the respective restriction enzymes and inserted at MCS in 
pmirGLO vector (Dual Reporter Luciferase Assay System, Promega) 
downstream to firefly luciferase reporter. Cropping of the hairpin stem-loop of 
the inserts results in destabilization of the firefly reporter leading to a decrease 
in firefly luminescence. The unperturbed renilla reporter produces stable 
luminescence, which serves as internal normalization control. Dual-luciferase 
reporters with pri-mir-182, and pri-mir-183 were transfected in N2a cells using 
cationic liposomes (Lipofectamine 2000 reagent, Invitrogen). The cells were 
lysed 48 hr post-transfection with passive lysis buffer (Promega) treatment at 
room temperature for 10 minutes. The lysates were then transferred to a 96 
well plate, and luciferase activities of firefly and renilla were read through 
luminometer GloMax 96 (Promega) equipped with dual injections dispersing 
LAR II (for firefly luciferase quantification) and Glomax (for renilla luciferase 
quantification) reagents sequentially.    	  
Production of plasmid for miRNA overexpression 
The scAAV2-EF1a-pri-miR-183/96/182-GFP construct was produced by cutting 
scAAV2-MCS (Cell Biolabs) by BalI/NotI (New England Biolabs). The 
transgene cassette containing Ef1a promoter (sequence from pEGP-mmu-
miR-182 plasmid; Cell Biolabs), engineered truncated (T)-pri-miR-183/96/182, 
EGFP (from pEGP-mmu-miR-182 plasmid; Cell Biolabs), WPRE motif and 5’-
BalI and 3’-NotI adapters was chemically synthesized by GENEWIZ (South 
Plainfield, USA) and cloned into the scAAV backbone. Sequence of T-pri-miR-
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183/96/182 was as follows with mature miRNAs 
underlined:5’cctctgcagggtctgcaggctggagagtgtgactcctgtcctgtgtatggcactggtagaatt
cactgtgaacagtctcagtcagtgaattaccgaagggccataaacagagcagagacagatccgcgagca
ccttggagctcctcacccctttctgcctagacctctgtttccaggggtgccagggtacaaagacctcctctgctc
cttccccagagggcctgttccagtaccatctgcttggccgattttggcactagcacatttttgcttgtgtctctccgct
gtgagcaatcatgtgtagtgccaatatgggaaaagcgggctgctgcggccacgttcacctcccccggcatcc
cataataaaaacaagtatgctggaggcctcccaccatttttggcaatggtagaactcacaccggtaaggtaat
gggacccggtggttctagacttgccaactatggtgtaagtgctgagct. The scAAV2-EF1a-pri-
miR-183/96/182-GFP allowed the generation of mature miR-183-5p, miR-96-
5p, and miR-182-5p sequences annotated in miRBASE v.20 
(www.mirbase.org), whose expression was verified both by RT-qPCR and 
Northern blot analysis in HEK293 cells transfected with scAAV2-EF1a-pri-miR-
183/96/182-GFP plasmid (data not shown). We also verified that expression of 
these miRNAs in HEK293 cells leads to specific repression of reporter mRNAs 
bearing miR-183/96/182 sites (data not shown). Control scAAV2-EF1a-control-
GFP construct contained fragment of beta-globin intron (sequence from pEGP-
mmu-miR-182 plasmid; Cell Biolabs) of length corresponding to T-pri-miR-
183/96/182.  
 
scAAV production  
Self-complementary AAV production was performed by triple transfection of 
HEK 293T cells using polyethylenimine with a plasmid bearing the target 
sequences between the internal terminal repeats of scAAV2, the AAV-helper 
plasmid encoding Rep2 and Cap for serotype 8, and the pHGTI-Adeno1 
plasmid harboring helper adenoviral genes (both kindly provided by C Cepko, 
Harvard Medical School, Boston, MA, USA). Vectors were purified using a 
discontinuous iodixanol gradient (Sigma, Optiprep). Encapsidated DNA was 
quantified by TaqMan RT-PCR following denaturation of the AAV particles by 
Proteinase K, and titers were calculated as genome copies (GC) per ml. 
 
Stereotaxic surgery and intra-hippocampal injections 
To overexpress miRNAs, virus vectors were prepared as described above. The 
oligonucleotides were stereotaxically injected in to the CA1 region of the 
hippocampus at a concentration of 1ug/ul, in TurboFect in vivo transfection 
reagent (Dharmacon). To carry out injections, animals were anaesthetized with 
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3% isofluorane (Attane™) and placed in a stereotaxic frame. Anaesthesia was 
maintained with 1.5% isofluorane in 100% oxygen throughout the surgery. 
Injection was carried out by lowering a glass pipette (Blaubrand®, cut to a 
20um inner diameter) filled with virus/oligonucleotides and attached to an 
injection pump (Stoelting) through a predrilled hole at the following coordinate 
targeting CA1 region of the hippocampus (from Bregma): AP: -2.0mm, ML: +/- 
1.5mm, DV: -1.6mm. A total of 1ul (109GC/ml) of virus vector or 1.5ul of TSB 
oligos was injected into each hippocampus at a rate of 0.2ul/min. The glass 
pipette was left in place for an additional 5 minutes, before it was carefully 
withdrawn and the wound was closed. The animals were allowed to recover for 
up to 2 weeks in their home cage before behavioral testing.  
 
RNA extraction and RT-qPCR 
Mouse hippocampal tissue was homogenized using TissueLyser (Qiagen) in 
Trizol® reagent (Invitrogen). Total RNA was extracted by phenol-chloroform 
precipitation. For extraction from cells, the medium was removed, the cells 
were washed three times with ice cold-PBS, lysed and homogenized by adding 
Trizol® directly to the plates. Subcellular fractionation of nuclear and 
cytoplasmic RNA was performed using Norgen’s Cytoplasmic and nuclear 
RNA purification kit (Norge BioTek, Canada). One microgram of total RNA was 
treated with RNase free DNase (Promega) and reverse transcribed using 
miScript II RT kit® (Qiagen). Miscript primer assays for mature and precursor 
miRNAs were used to amplify the respective transcripts from a cDNA pool 
(Supplementary Table 1). For mRNA quantification, custom designed or 
Quantitect (Qiagen) gene specific primers were used (Supplementary Table: 
under preparation). Real time PCR was performed on LightCycler 480® 
(Roche). Small nuclear RNA (RNU6) or GAPDH was used as endogenous 
control and quantification was performed as previously.18 
 
Protein extraction and Western blot 
Total protein was extracted from N2A cells using radio immunoprecipitation 
buffer (RIPA) with 1:1000 protease inhibitor cocktail (Sigma-Aldrich) and 1:500 
phenyl methyl sulfonyl fluoride (PMSF). Cells were lysed directly on the culture 
plate with 100-150 ul RIPA and scraped off with a cell scraper. The lysate was 
transferred to a micro centrifuge tube and sonicated for 5 cycles, each 
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comprising 30 seconds of sonication with 30 seconds intervals. The resulting 
mixture was centrifuged for 15 minutes at 14,000g to separate the protein 
mixture (supernatant) from cellular debris (pellet). Nuclear proteins were 
extracted from N2a cells as described in the section ‘PP1 activity assays’. 20-
40 ug proteins were resolved on SDS-PAGE and transferred onto a 
nitrocellulose membrane (Bio-rad). Membranes were blocked in 3% BSA for 
one hour, and then incubated in primary (overnight at 4oC) and secondary (one 
hour at room temperature) antibodies. They were scanned using Odessey IR 
scanner (Li-Cor Bioscience), and band intensity was determined and quantified 
using image analysis software (ImageJ). The following antibodies were used: 
primary – phospho SMAD 1/5 Ser 463/465 (Cell Signaling Technology, mAb 
9516), Drosha  (Abcam, ab135956), DGCR8 (Abcam, ab35865), Cyclophilin A 
(Abcam, ab58144), HistoneH3 (Abcam, ab 1791), GAPDH (Abcam, ab 9485); 
secondary – anti-mouse IRDye® goat anti-mouse (LI-COR, 925-32210) and 
IRDye® goat anti-rabbit (LI-COR, 925-32211). 
 
Statistical analysis 
To confirm discrimination of novel object by the animals during memory testing 
against a predefined chance level, one-sample Student t test was used. For 
behavioral/molecular data comparison between two groups, unpaired Student t 
test was used, with additional Welsch correction in cases where the variances 
were unequal between the two groups. For data involving comparison between 
more than two groups, one-way ANOVA was used. To check the effect of 
aging on miRNA upregulation upon learning, two-way ANOVA was employed. 
Significant ANOVA analyses were followed by post-hoc pair-wise comparisons. 
Tukey’s post-hoc was used when pair-wise comparisons between all the 
groups were required. In selected cases requiring pair-wise comparisons 
between a specific group versus the control, Sidak post-hoc was used. Outliers 
were defined as values beyond two standard deviations from the group mean 
and were removed from the analysis. Significance was set at p < 0.05 for all 
tests and two-sided tests were performed. Statistical analysis was performed 
using GraphPad prism version 7 and verified by SPSS version 23. All graphs 
were drawn with GraphPad prism version 7.  
 
Jawaid 2016 
 
   
93	  
3.4. Acknowledgments 
This work was supported by the University of Zurich, the Swiss Federal 
Institute of Technology, the Swiss National Science Foundation and the 
National Competence Center for Research “Neural plasticity and Repair”. We 
thank Vinnie Kandra, Jennifer Brown, Tariq Afroz, Ingrid Berg, Lukas 
Schmidheini, Julia Bollharder, and Lubka Spassova for technical help, Jean-
Claude Paterna for virus production, animal caretakers for mouse colony 
management, Sebastian Jessberger and Constance Ciaudo for constructive 
discussion and critical reading of the manuscript. 	  
3.5. Authors’ contribution 
A.J and I.M.M initiated and designed the study, analyzed the results and wrote 
the manuscript. A.J performed behavioral experiments, did molecular analysis 
of brain samples, and designed and executed in vitro experiments. B.T.W 
performed stereotaxic injections, co-immunoprecipitation experiments with 
N.G., and helped in the interpretation and drafting of in vivo data. E.A.K. 
conducted environment enrichment and performed luciferase assays with A.J. 
N.G and A.J conducted qPCR experiments and Western blots. M.P. and J.R. 
provided human samples with TDP-43 pathology and critical input to the 
manuscript.  
 
 
 
 
 
 
 
 
 
 
 
 
Jawaid 2016 
 
   
94	  
3.6. Figures and Figure Legends 
 
 
 
Fig. 1.  miR-183/182 and their regulation by nuclear PP1 are implicated in ARCD. 
(a) Performance of young (4-5 months old) and aged (20-21 months old) mice tested 
24 and 48 hours after NOR training, expressed as discrimination index. At both 24 and 
48 hours, only young animals demonstrate significant discrimination for the novel 
object (chance level set at 33.3%) (24 hours: one-sample t-test, control: 33.3%, 
p<0.05; 48 hours: one-sample t-test, control: 33.3%, p<0.05). Additionally, young mice 
had better performance than aged at 48 hours (unpaired t test: *p<0.05). Young, n=9, 
aged, n=8.  
(b). Young  (4-5 months old) and aged (20-21 months old) mice were trained on an 
NOR task. Hippocampal samples were collected from each group 30min after the end 
of training. The effect of NOR training on hippocampal expression of miR-183 and 182 
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was compared between young and aged mice. NOR training increased miR-183 (left) 
and 182 (right) in young, but not in aged mice (two-way ANOVA: miR-183: F: 
1,17=3.399, p=0.0021, post-hoc: young **p<0.01, aged p=0.618, miR-182: F: 
1,17=11.04, p=0.004, post-hoc: young **p<0.01, aged p=0.978). Young, n=6, aged, 
n=6.  
(c) NOR training increased pre-mir-182 (left panel) in young (4-5 months old), but not 
in aged (20-21 months old) mice. However, NOR training increased pri-mir-
183/96/182 in both young and aged mice (right panel) (two-way ANOVA: pre-mir-183: 
F 1,15=1.555, p=0.23, post-hoc:  young p=0.15, aged p=0.99; pre-mir-182: F 
1,15=5.908, p=0.028, post-hoc: young *p<0.05, aged p=0.99; pri-mir-183/96/182: F 1, 
15=22.42, p=0.0006, post-hoc: young **p<0.01, aged # p<0.1). Young, n=6, aged, 
n=6.    
(d) Increased nuclear PP1 activity in hippocampal tissue collected from aged (20-21 
months old) mice compared to young (<6 months old) (unpaired t test:  *p<0.05). 
Aged, n=4, young, n=4. 
(e) Hippocampal over-expression of miR-183/182 in aged mice reverses age-related 
memory decline. Memory performance of young (4-5 months old), vehicle-injected 
aged (20-21 months old), and miRNA-injected aged (20-21 months old) mice was 
tested 24 and 48h after NOR training, expressed as discrimination index.  Young mice 
demonstrate significant discrimination of the novel object at both 24 and 48h (24 
hours: one-sample t-test, control: 33.3%, p<0.1; 48 hours: one-sample t-test, control: 
33.3%, p<0.05). miRNA-injected aged mice show significant discrimination of the 
novel object at 48h (one-sample t test, control: 33.3%, p<0.01). MiRNA-injected aged 
mice show increased discrimination for the novel object as compared to vehicle-inject 
aged mice at 48h (one-way ANOVA, F 2, 14=6.018, p=0.01, post-hoc: young *p<0.05, 
miR-183/96/182 injected aged *p<0.05). Young, n=4, vehicle-injected aged, n=8, miR-
183/96/182 injected aged, n=8.  
(f) Environment enrichment  (EE) decreased hippocampal nuclear PP1 activity in aged 
mice. Left panel: nuclear PP1 activity in the hippocampal tissue collected from aged 
(19-21 months old) mice exposed to four weeks of EE was significantly decreased 
compare to standard-housed aged (19-21 months old) mice (unpaired t test, *p<0.05). 
Right panel: Increased mRNA expression of PP1 inhibitor PP1R1A and NIPP1 in 
hippocampal tissue collected from aged  (19-21 months old) mice exposed to four 
weeks of EE compared to standard-house aged (19-21 months old) mice (unpaired t 
test: PP1R1A: *p<0.05, NIPP1: #p<0.1). Standard housed aged, n=8, aged with EE, 
n=8.  
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Fig.2. miR-183/182 and their regulation by nuclear PP1 contribute to non-
genomic blockade of cognitive functions in TDP-43 proteinopathies.  
(a) Decreased microprocessor processing of pri-mir-183 and pri-mir-182 in mouse 
N2a cells with TDP-43 knock-down. N2a cells were transfected with dual-luciferase 
reporters harboring pri-mir-183 and pri-mir-182 under TDP-43 (right) siRNA-mediated 
knock downs. TDP-43 knock-down decreased microprocessor processing of pri-mir-
183 and pri-mir-182 (right), expressed as increased firefly/renilla luminescence 
(unpaired t test: pri-mir-183: *p<0.05; pri-mir-182: *p<0.05). Negative control siRNA, 
n=4, α-synuclein siRNA, n=4, FUS siRNA, n=4, TDP-43 siRNA, n=4.  
(b) Increased nuclear PP1 activity in mouse N2a cells treated with TDP-43 siRNA 
compared to Negative control siRNA (unpaired t test, *p<0.05). Negative control 
siRNA, n=4, TDP-43 siRNA, n=4.  
(c) Decreased expression of miR-183, miR-96, and miR-182, but not of a control 
miRNA miR-10b compared to age-matched controls in cortical tissue collected from 
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patients with ALS/FTLD (unpaired t test: miR-183: ***p<0.001; miR-96: ***p<0.001; 
miR-182: ***p<0.001; miR-10b p=0.389). Controls, n=8, ALS/FTLD, n=10. 
(d) Increased expression of targets of miR-183/96/182 compared to age-matched 
controls in cortical tissue collected from patients with ALS/FTLD (unpaired t test: 
HDAC9: *p<0.05; NUFIP1: p=0.276; GRM: *p<0.05; GRIA: # p<0.1). Controls, n=8, 
ALS/FTLD, n=10.  
(e) Increased expression of PP1γ compared to age-matched controls in cortical tissue 
collected from patients with ALS/FTLD (unpaired t test, *p<0.05). Controls, n=8, 
ALS/FTLD, n=10.  
(f) Model representing regulation of miR-183/96/182 biogenesis by nuclear PP1. miR-
183/96/182 are produced by the canonical pathway of miRNA biogenesis, involving 
transcription through RNA polymerase II into a single pri-mir-183-96-182 (1), which is 
further processed by Drosha/DGCR8 microprocessor complex into three different 
precursors, pre-mir-183, -96, -182 (2). These precursors are exported out into the 
cytoplasm through exportin 5 (3) and further processed by Dicer into mature miRNAs 
(4). Activated phospho-SMAD 1/5 localize to the nucleus to preferentially increase the 
micorprocessing of pri-mir-183-96-182 by binding to the SMAD-binding element 
present on its terminal loop, and microprocessor accessory component p68 (5).  
Increase in nuclear PP1 activity with aging and/or with TDP-43 loss of nuclear 
function, dephosphorylates SMAD 1/5, thus impairing their interaction with 
microprocessor accessory component p68 and pri-mir-183-96-182, resulting in 
decreased biogenesis of miR-183/96/182  (6).  
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3.7. Supplementary Figures 
 
 
 
 
Supplementary Fig. 1: Novel object recognition (NOR) training of mice (a) 
Experimental set-up of NOR training, followed by memory testing defined by 
discrimination for the novel object, performed at 24 hours and 48 hours post-training. 
(b) Experimental set-up of object exploration conducted prior to tissue collection for 
analysis of miR-183/96/182 expression in the hippocampus.  
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Supplementary Fig. 2: Altered expression of PP1 regulators with aging. Hippocampal 
tissue collected from aged (20-21 months) mice showed an increased expression of 
AKAP1 and PP2CA, and decreased expression of PP1R1A compared to young (4-5 
months old) mice (unpaired t test: AKAP1: unpaired t test, #p<0.1; PP1R1A: *p<0.05; 
PP2CA: *p<0.05). Young, n=6, aged, n=6. 
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Supplementary Fig. 3: Hydroxyurea (HU) induces cellular senescence in mouse 
neuroblastoma (N2a) cells. Treating N2a cells with 8mM HU increased the mRNA 
expression of senescent markers p21 and p53 compared to vehicle treatment  
(unpaired t test: p21: ****p<0.0001; p53: ****p<0.0001). Vehicle, n=4, HU, n=4.  
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Supplementary Fig. 4: Decreased microprocessor processing of pri-mir-183, 
expressed as increased firefly/renilla luminescence, on HU-induced senescence, 
as well as, PP1γ over-expression in N2a cells (one-way ANOVA, F 2,9=5.772, 
p=0.02, post-hoc: HU *p<0.05, PP1γ *p<0.05). Vehicle, n=4, HU, n=4, PP1γ over-
expression, n=4.   
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Supplementary Fig. 5: Nuclear PP1 does not regulate the expression of 
Drosha/DGCR8. Representative blots (left) and quantification (right) of Drosha and 
DGCR8 protein in the N2a cells after NIPP1 and PP1γ over-expression. Drosha (one-
way ANOVA, F 2,5=0.215, p=0.814), DGCR8 (one-way ANOVA, F2,5=2.016, 
p=0.248). Control, n=3, NIPP1 over-expression, n=3, PP1γ over-expression, n=3.  
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Supplementary Fig. 7: Nuclear PP1 regulates SMAD 1/5 phosphorylation. 
Representative blot (left) and quantification (right) of phospho-SMAD1/5 in N2a cells 
after NIPP1 over-expression showing an increase in their protein expression (unpaired 
t test: *p<0.05). Control, n=3, NIPP1 over-expression. n=3.  
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Supplementary Fig. 8: PP1 regulates SMAD-dependent miRNA. miR-21, a miRNA 
regulated at the microprocessor level by R-SMAD, is non-significantly decreased in 
N2a cells on NIPP1 over-expression (unpaired t test: #p<0.1). Control, n=4, NIPP1 
over-expression, n=4.  
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Supplementary Fig. 9: SMAD5 selectively regulates microprocessor processing of pri-
mir-183/96. Decreased microprocessor processing of pri-mir-183, expressed as 
increased firefly/renilla luminescence ratio, but not of a control miRNA pri-mir-10b, on 
SMAD5 knock down in N2a cells (unpaired t test: pri-mir-183: *p<0.05; pri-mir-10b: 
p=0.487). Negative control siRNA, n=4, SMAD5 siRNA, n=4.  
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Supplementary Fig. 12: Environment enrichment (EE) in aged  (19-21 months old) 
mice upregulates miR-183/182, as well, as their precursors. Increased expression of 
miR-183 and -182, and their precursors in hippocampal tissues collected from aged 
mice treated with four weeks of EE compared to aged mice with standard housing 
(unpaired t test: miR-183: #p<0.1; miR-182: *p<0.05; pre-mir-183: #p<0.1; pre-mir-
182: *p<0.05). Aged (standard-housed), n=6, aged (environment enriched), n=6.   
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Supplementary Figure 14:  Effect of TDP-43 on microprocessor processing of pri-mir-
183/96 is PP1 dependent. Decreased microprocessor processing of pri-mir-183/96 on 
TDP-43 knock down is reversed in the presence of 20 nM (inhibits PP1/PP2A), but not 
with 0.1nM Okadaic acid (inhibits PP2A) (one-way ANOVA: F 3,10=27.55, p<0.0001, 
post-hoc: siRNA TDP-43 *p<0.05, siRNA TDP-43+ 20nM Okadaic acid ****p<0.0001). 
Negative control siRNA, n=4, TDP-43 siRNA, n=3, TDP-43 siRNA+0.1 nM Okadaic 
acid, n=3, TDP-43 siRNA+20nM Okadaic acid, n=4) 
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Supplementary Figure 15: Unchanged mRNA expression of Drosha and DGCR8 on 
TDP-43 knock-down compared to a negative control (unpaired t test: Drosha: 
p=0.631; DGCR8: p=0.605). Negative control siRNA, n=4, TDP-43 siRNA, n=4. 
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4. Discussion 
 
Our findings newly reveal a role for miRNA cluster miR-183/96/182 in formation 
of long-term memory (LTM) in mammals. They further show that nuclear 
protein phosphatase 1 (PP1) regulates miR-183/96/182 biogenesis to fine-tune 
their expression upon learning. Importantly, age-related cognitive decline 
(ARCD) and cognitive dysfunction associated with TDP-43 proteinopathies (CD 
TDP) involve an increase in nuclear PP1 activity and consequential impairment 
in the biogenesis of miR-183/96/182.   
 
4.1. Hippocampal miR-183/96/182 regulate memory 
Our study is the first investigation showing a collective role for miRNA cluster 
183/96/182 in formation of LTM. However, individually miR-182 has been 
previously implicated in amygdala-dependent fear memory (Griggs et al. 2013). 
Griggs et al. showed that miR-182 is down regulated in mouse lateral 
amygdala (LA) after auditory fear conditioning. Importantly, over-expression of 
miR-182 in mouse LA disrupted fear memory (Griggs et al. 2013). This is in 
contrast to our study, where we observed an increase in hippocampal miR-
182, along with its partners miR-183 and miR-96 upon learning. There are 
several reasons, which could have lead to a disparity between these two 
studies. First, there are differences in the molecular/structural underpinnings of 
fear versus object recognition memory. For example, fear memory shows a 
greater dependency on the structural connectivity between different cortical 
hemispheres compared to object recognition memory according to studies on 
mice with agenesis of the corpus callosum (MacPherson et al. 2008). Second, 
it is possible that the functionality and regulation of miR-182 are different in 
different neuroanatomical regions. miRNA expression is known to complement 
the expression of their targets (Ha & Kim, 2014), and it is possible that the 
targets of miR-182 are differentially expressed in different brain regions, 
necessitating the need for comparative baseline expression of miR-182. For 
example, BDNF, a known target of miR-182 is decreased in area CA3 of 
hippocampus, but increased in basolateral amygdala in mice after chronic 
immobility stress (Lakshminarasimhan & Chatterji, 2012). It is possible that the 
stressful response elicited during auditory fear conditioning increases BDNF in 
LA of mice, necessitating a decrease in LA miR-182, whereas, the memory 
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component of auditory fear conditioning still increases miR-182 in the 
hippocampus. Similarly, Rac1, a target of miR-182, which is increased in 
mouse LA according to Griggs et al. is decreased in the hippocampus after 
spaced fear training in rats (Jiang et al. 2016). Finally, recently it has been 
pointed out that the last member of miRNA clusters can be subjected to 
different post-transcriptional regulation than the other members under specific 
conditions (Du et al. 2015). Hence, it is possible that the disparate expression 
of miR-182 in mouse LA and hippocampus in these two classical memory 
paradigms will not extend to other members of the cluster, i.e., miR-183 and 
miR-96.  
 
MiR-183/96/182 were previously shown to exhibit an activity-dependent 
turnover in the mouse retinal cells (Krol et al. 2010). We show that this 
dynamic turnover characteristic of miR-183/96/182 also extends to neurons. 
The level of mature miR-183/96/182 immediately decreases with neuronal 
activity in N2a cells. However, this early decrease is followed by a subsequent 
increase on long-term stimulation. This subsequent increase in their 
expression is blocked when N2a cells are treated with transcriptional inhibitor 
Actinomycin D, suggesting that neuronal activity leads to a rapid usage of the 
pool of available miR-183/96/182, which are then replenished through 
transcriptional increase in their biogenesis. Importantly, inhibition of nuclear 
PP1 restocks the pool of mature miR-183/96/182 in the absence of 
transcription by increasing their post-transcriptional processing through the 
microprocessor complex. This may become vital in conditions, where the 
physiological transcriptional increase in miR-183/96/182 upon neuronal activity 
is sub-optimal. For instance, aging is known to decrease global transcription in 
the brain (Park et al. 2015), possibly by decreasing the activity of transcription 
factors, such as NF-κB (Southwork et al. 2009). Similarly, high levels of 
oxidative stress inhibit gene transcription, partly through changes in histone 
acetylation (Berthiaume et al. 2006). Indeed, both these conditions are 
associated with impairment in multiple cognitive domains in mammals (Fukui et 
al. 2002). Artificially increasing hippocampal level of miR-183/96/182, 
therefore, becomes a potential therapeutic candidate to rescue cognitive 
deficits associated with such conditions. ARCD was indeed partially reversed 
by over-expression of miR-183/96/182 in this study. In future, it will be 
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interesting to investigate if miR-183/96/182 have the potential to rescue the 
cognitive deterioration associated with conditions of high oxidative stress in the 
brain, such as ischemic stroke (Nathaniel et al. 2015) and traumatic brain injury 
(Rodriquez-Rodriquez et al. 2014).  
 
The bi-directional effect of miR-183/96/182 in this study strongly establishes 
their role in regulation of hippocampus-dependent memory. Artificial over-
expression of miR-183/96/182 in mouse hippocampus enhanced, whereas, 
their hippocampal inhibition impaired, LTM after a weak protocol of novel 
object recognition (NOR) training. These effects are likely attributed to a 
combinatorial action of multiple targets of miR-183/96/182. Indeed, we found 
significant decrease in various targets of miR-183/96/182 in mice over-
expressing the cluster. One such target Neuregeulin 1 (NRG1) regulates the 
intricate balance between excitatory and inhibitory connections within the brain, 
and its dysfunction is implicated in schizophrenia (Agarwal et al. 2014).  Two 
other targets, GRM5 and PP2CA are associated with ARCD (Ménard & 
Quirion, 2012) and Alzheimer disease (Sontag & Sontag, 2014) respectively. 
Similarly, NUFIP2 is linked to Fragile X intellectual disability (Bardoni et al. 
1999). Finally, another target is HDAC9, a histone deacetylase, whose 
inhibition enhances cognition in mice (Gräff et al. 2013).   
 
To show that manipulation of miR-183/96/182 targets can recapitulate the 
phenotypic effects of miR-183/96/182 over-expression/inhibition, we chose 
HDAC9 for further analysis. After validating a direct interaction between miR-
182 and HDAC9 through luciferase assays, we interfered with miR-182 binding 
to HDAC9 in vivo through locked nucleic acid (LNA) technology based target-
site blockers. This interference impaired object exploration in mice, without an 
appreciable effect in LTM. This result is not unexpected, considering only one 
target of miR-183/96/182 was blocked. Multiple targets of a miRNA are 
sometimes functionally redundant (Allen et al. 2007), requiring their 
combinatorial suppression by the miRNA to produce a detectable phenotype. 
HDAC9 is even more unique in this case as it belongs to a family of enzymes 
known to be functionally identical (Haberland et al. 2009). Hence, it is likely 
that HDAC9 manipulation did not produce a cognitive phenocopy of miR-
183/96/182 inhibition due to a compensatory contribution from other miR-
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183/96/182 targets and/or HDACs. Regardless, interfering with HDAC9 
impaired exploratory behavior in mice, which is a crucial pre-requisite of LTM 
formation. This suggests that the cognitive phenotype of hippocampal miR-
183/96/182 is mediated, in part, through HDAC9.   
 
Bioinformatics analysis using DIANA tools miR-path software on miR-
183/96/182 targets reveals their involvement in multiple molecular pathways 
associated with cognitive functioning (Table 1).  
 
Table 4.1: Biological pathways potentially regulated by miR-183/96/182 
miRNA Five most affected pathways  
miR-183 Transcriptional regulation, Wnt signaling, dopaminergic neurotransmission, glycan 
degradation, tight junctions 
miR-96 Regulation of actin cytoskeleton, MAPK signaling, prostate cancer, axon 
transport, long-term potentiation 
miR-182 Long-term depression, neurotrophin signaling, bacterial invasion of epithelial 
cells, oocyte meiosis, long-term potentiation 
 
Our investigation provides experimental evidence in support of the bio-
informatics analysis by revealing transcriptional regulator HDAC9 as a 
validated target of miR-183/182. Similarly, two other targets found decreased 
in mouse hippocampus after miR-183/96/182 over-expression, NGR1 and 
Protein kinase C zeta (PRKCZ) (Kwon et al. 2008, Sackter, 2008), have been 
invariably reported to regulate LTP and LTD. In future investigations, it will be 
crucial to study LTP and LTP in mice with hippocampal over-expression and 
inhibition of miR-183/96/182.  
 
Further to LTP/LTD, another molecular pathway likely implicated in mediating 
the cognitive effects of miR-183/96/182 is adult neurogenesis, which is 
increasingly associated with memory formation and re-consolidation in 
mammals (Suarez-Pereira & Carrion, 2015). Importantly, the expression and 
activity of HDAC9 is uniquely suppressed in adult neural stem cells through all 
stages of neural differentiation, allowing an expression exclusively in post-
mitotic neurons (Lang et al. 2012). Expression of miR-183/96/182 and their 
targets in neural stem cells, as well as, their contribution to adult hippocampal 
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neurogenesis for memory formation and re-consolidation may make an 
important subject for future investigations.    
 
Finally, miR-183/96/182 may regulate memory through their control of DNA 
repair mechanisms (Krishnan et al. 2013). Activity-induced DNA breaks have 
been identified as a key mechanism governing expression of immediate early 
genes (IEGs) in the mouse brain (Madabhushi et al. 2015). Considering the 
critical role of IEGs in memory formation, it is possible that miR-183/96/182 
may make an important contribution to this pathway by suppressing DNA 
repair mechanisms, thus allowing persistent activity-induced DNA breaks.  
 
These predicted and validated roles of miR-183/96/182 in key regulatory hubs  
controlling cognitive functions in mammals make them attractive therapeutic 
candidates for treatment of cognitive disorders. MiRNA-based therapeutics, 
involving both gain- and loss-of-miRNA-function are being increasingly 
attempted in the cancer field (Woldemichael & Mansuy, 2016). However, a 
widespread and effective use of miRNA therapeutics has been hampered due 
to the limited cellular permeability of miRNA modulating oligonucleotides owing 
to their large size and negatively charged backbone (Schmidt, 2014). This 
problem could be even more pertinent for miR-183/96/182 delivery in the brain 
due to the impeding blood-brain barrier. In recent years, drug formulations that 
overcome these challenges by packaging the oligonucleotide inside ionizable 
liposomal nanoparticles or through LNA-modification of negative charged 
backbones have been developed for some miRNAs (Bader et al., 2011). In 
future, it will be interesting to see if these innovative strategies can increase 
the brain uptake and penetration of miR-183/96/182 allowing their targeted 
delivery to specific brain regions of interest.    
 
Another challenge related to the therapeutic potential of miR-183/96/182 is 
their widespread influence on gene regulation, which could lead to undesirable 
effects. For instance, a recent study has revealed that miR-182 over-
expression in mouse hippocampus may lead to pro-depressive behaviors (Li et 
al. 2015). This could be a possible off-target effect as artificial miRNA 
overexpression can perturb several target genes, and may also trigger multiple 
compensatory pathways. One means of tackling this challenge could be 
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meticulous analysis of miRNA targets implicated in cognition versus 
depression, followed by selective disruption or enhancement of interaction 
between miR-183/96/182 and their specific memory-relevant targets through 
LNA target site blockers.  
 
4.2. PP1 regulates the biogenesis of miR-183/96/182 
MiR-183/96/182 are produced through the canonical pathway of miRNA 
biogenesis involving transcription of pri-mirs, their processing into pre-mirs 
through the Drosha-DGCR8 microprocessor in the nucleus, export into the 
cytoplasm, and conversion into mature miRs by Dicer (Ha & Kim, 2014). Based 
on the observation that miR-183/96/182 are up regulated in the hippocampus 
of NIPP1* mice, we questioned how nuclear PP1 regulates the nuclear 
biogenesis of these miRNAs. Early biogenesis of miR-183/96/182 could be 
regulated by PP1 for a number of reasons.  PP1 can regulate the occupancy of 
RNA pol II on the promoter region of a number of genes, for example, CREB 
and NF-κB, thereby regulating their transcription (Koshibu et al. 2009). CREB 
and NF-kB, themselves, regulate the transcription of many miRNAs (Taganov 
et al. 2006, Nudelman et al. 2010). Further, activity of RNA pol II can be altered 
by PP1 through dephosphorylation of its C-terminal domain (Hirose & Ohkuma, 
2007). Beyond this transcriptional control, PP1 could also regulate the 
biogenesis of miR-183/96/182 post-transcriptionally through regulating the 
expression, sub-cellular localization, and activity of major components of the 
nuclear microprocessor (Tang et al. 2010, Tang et al. 2011, Herbert et al. 
2013).     
 
By using transcriptional silencing assays, we very judiciously demonstrated 
that regulation of miR-183/96/182 is transcription-independent. A 
transcriptional-dependence would have lead to a reversal of pre-mir-
183/96/182 up regulation on inhibition of nuclear PP1 in the absence of 
transcription. Contrary to this, we observed a decrease in the pri-mir-183-96-
182 and a persistent up regulation of pre-183/96/182 when nuclear isoform of 
PP1, PP1γ was knocked down even with transcriptional silencing. This was 
complemented by the results of neuronal activity assays, which revealed that 
PP1γ knock down replenished the mature miR-183/96/182 in the absence of 
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transcription. Together, these results established that PP1 regulates miR-
183/96/182 biogenesis post-transcriptionally.   
 
We next investigated if nuclear PP1 regulates Drosha-DGCR8 microprocessor 
complex. Neither the expression nor the sub-cellular localization of 
Drosha/DGCR8 was altered on manipulating nuclear PP1 in our study. 
Importantly, while microprocessor processing of artificially introduced pri-mir-
183/96 and pri-mir-182 was enhanced on nuclear inhibition of PP1 in N2a cells, 
microprocessor-mediated biogenesis of a control miRNA miR-10b was 
unperturbed. These mechanistic studies indicate that regulation of the 
microprocessor-mediated biogenesis of miRNAs by nuclear PP1 is selective 
for miR-183/96/182. Indeed, only a hand full of miRNAs were differentially 
regulated in the hippocampus upon NIPP1* induction in mice, which is in 
agreement with the in vitro microprocessor activity assays.   
 
The intriguing finding that nuclear PP1 can selectively regulate the 
microprocessor-mediated biogenesis of miR-183/96/182 is an important 
addition to the repertoire of evidence supporting the notion that activity of 
microprocessor can be selectively regulated by certain factors and/or under 
certain conditions (reviewed in Ha & Kim, 2014). As mentioned previously, a 
majority of these ‘microprocessor regulators’ include RNA binding proteins, 
which either bind to certain pri-mirs and preferentially increase or decrease 
their cleavage by the microprocessor, or interfere with the binding of Drosha 
and DGCR8 (Ha & Kim, 2014). Off particular interest to us among these 
‘microprocessor’ regulators were MeCP2 and R-SMADs, as their nuclear 
expression and activity depend on phosphorylation, making them vulnerable to 
changes in nuclear PP1 (Li et al. 2014, Wrighton et al. 2009). Using Western-
blot based phosphorylation assays, we identified that phosphorylation of SMAD 
1/5 can be regulated by nuclear PP1 (Chapter 3), whereas, MeCP2 
phosphorylation did not vary with increase in nuclear PP1 (Fig. 4.1 left).  
Interestingly, SMAD 5 mRNA expression, along with that of KSRP, was 
regulated by nuclear PP1 as well (Fig. 4.1 right).      
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Fig. 4.1. Nuclear PP1 controls the expression of known microprocessor 
regulators. (left) NIPP1 over-expression did not alter the protein expression of 
phospho-MeCP2 in the nuclear fraction of mouse N2a cells (unpaired t test: p=0.819). 
(right) NIPP1 over-expression decreased the mRNA expression of SMAD-5 and 
KSRP in mouse N2a cells (unpaired t test: SMAD-5: p<0.05; KSRP:*p<0.05). Control, 
n=4, NIPP1 over-expression, n=4.  
 
SMAD proteins are down-stream signaling molecules of transforming growth 
factor- beta (TGF-β) and bone morphogenic protein (BMP), which translocate 
to the nucleus on activity-induced phosphorylation. Together, with SMAD-4 
(also known as co-SMAD), R-SMADs control the expression of multiple genes 
transcriptionally (reviewed in Massgué, 2012). However, the regulation of 
microprocessor by R-SMADs is independent of co-SMAD, and involves their 
interaction with microprocessor accessory protein p68 (Davis et al. 2008, Davis 
et al. 2010, Blahna & Hata, 2012). Control of nuclear SMAD 1/5 
phosphorylation by PP1, combined with their known role in selectively 
regulating the microprocessor processing, makes them a likely mediator for the 
selective regulation of miR-183/96/182 by nuclear PP1. This possibility was 
verified through multiple modalities: 1) a confirmation of the selective effect of 
SMAD 5 on microprocessor processing of pri-mir-183 and pri-mir-182, similar 
to their regulation by nuclear PP1, 2) altered expression of miR-21, a SMAD-
dependent miRNA in N2a cells after PP1 manipulation, and 3) bio-informatics 
validation of presence of SMAD binding element on pri-mir-183-96-182. Taken 
together, these results strongly suggest R-SMADs as intermediates between 
nuclear PP1 and microprocessor processing of pri-mir-183-96-182 (Fig. 4.2).      
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Fig.4.2. Model representing regulation of miR-183/96/182 biogenesis by nuclear 
PP1. miR-183/96/182 are produced by the canonical pathway of miRNA biogenesis, 
involving transcription through RNA polymerase II into a single pri-mir-183-96-182 (1), 
which is further processed by Drosha/DGCR8 microprocessor complex into three 
different precursors, pre-mir-183, -96, -182 (2). These precursors are exported out into 
the cytoplasm through exportin 5 (3) and further processed by Dicer into mature 
miRNAs (4). Activated phospho-SMAD 1/5 localize to the nucleus to preferentially 
increase the microprocessing of pri-mir-183-96-182 by binding to the SMAD-binding 
element present on its terminal loop, and the microprocessor accessory component 
p68 (5).  Increase in nuclear PP1 activity dephosphorylates SMAD 1/5, thus impairing 
their interaction with microprocessor accessory component p68 and pri-mir-183-96-
182, resulting in decreased biogenesis of miR-183/96/182  (6).  
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Importantly, all the different components of this regulatory pathway depicted 
above have been linked with cognitive functions in mammals. While the role of 
PP1 as a negative regulator of memory is well established (Genoux et al. 
2002), deletion of DGCR8 was shown to impair neurogenesis and working 
memory in mice (Ouchi et al. 2013).  Similarly, TGF-β and down-stream SMAD 
signaling are essential for maintenance of LTP and hippocampal-dependent 
memory in mice (Caraci et al. 2015). Finally, our study has established a 
crucial down-stream role for miR-183/96/182 in formation of long-term memory 
in mice.  
 
Experimental evidence supporting this ‘nuclear PP1à R-SMADà 
Drosha/DGCR8 microprocessorà miR/183-/96-/182’ pathway could benefit 
from investigations confirming a direct interaction of pri-mir-183-96-182 with 
SMAD-5 through cross-linking immunoprecipitation (CLIP) analysis. Such 
analysis is expected to reveal an increased interaction of pri-mir-183-96-182 
with SMAD-5 and p68 complex on inhibition of nuclear PP1.  
 
From a therapeutic point of view, each component of this pathway has 
considerable potential to be employed for cognitive enhancement. Spaced 
learning; a known memory-enhancing paradigm, mediates its effects through 
inhibition of PP1 (Genoux et al. 2002, Waddell, 2003). In our study, spaced 
learning employed during strong NOR training protocol paralleled the effect of 
NIPP1* over-expression on memory formation, as well as, miR-183/96/182 
expression in mice. Importantly, spaced learning in NIPP1* mice did not have 
any additional effect on either their memory performance or their hippocampal 
miR-183/96/182 expression (unpublished data). Further, artificial over-
expression of miR-183/96/182 enhanced memory only in the weak NOR 
protocol, which does not employ spaced learning. These results reiterate that 
PP1 has a constraining role on memory formation, which can be 
physiologically removed through spaced learning paradigms and/or artificially 
over-expressing its down-stream effectors, miR-183/96/182. Interestingly, 
bacopa monneira, a traditional cognitive enhancer was recently shown to 
enhance long-term memory in rats through decrease in hippocampal PP1 and 
HDAC9, a target of miR-183/96/182 (Preethi et al. 2014). Similarly, mild 
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increase in ALK-5 dependent TGF-β signaling improves hippocampal-
dependent spatial memory through promoting late-adult neurogenesis (He et 
al. 2014) 
 
From a clinical perspective, further dissecting the regulation of miR-183/96/182 
by nuclear PP1, also in other learning paradigms, will not only reveal promising 
targets for memory disorders, but may also provide valuable clues in 
understanding the unique memory phenotype of post-traumatic stress disorder 
(PTSD). PTSD patients experience an exaggerated recall for traumatic 
memories accompanied by amnesia for the recognizable facts related to the 
traumatic event (Brewin & Holmes, 2003). Fear conditioning, a behavioral 
model for PTSD, decreases hippocampal miR-183/96/182 (unpublished data), 
which is contrary to their up regulation by NOR training. Similarly, Griggs et al. 
observed a decrease in amygdala miR-182 after auditory fear conditioning. It is 
possible that PP1 and miR-183/96/182 are differentially regulated in 
hippocampus versus amygdala during a traumatic event. Amygdala changes in 
PP1 and miR-183/96/182 during the traumatic event may underlie the 
exaggerated recall of traumatic memories, whereas the recognition memory 
could be impaired due to PP1 and miR-183/96/182 changes in the 
hippocampus. Dissecting these mechanisms further may aid in developing 
therapeutic strategies for PTSD. 
 
 
4.3. Impaired PP1-dependent biogenesis of miRNA-183/96/182 underlies 
cognitive dysfunction associated with aging 
The molecular mechanisms underlying ARCD have been proposed to involve 
protein phosphatases, in particular PP1 and CaN (Park et al. 2015). The 
results of our study confirm that increase in nuclear PP1 activity with aging 
underlies ARCD, and this effect is mediated through impaired nuclear 
biogenesis of miR-183/96/182.  
 
There are multiple plausible reasons for the increase in nuclear PP1 activity 
with aging. The first possibility could be an increased expression of nuclear 
isoform of PP1, PP1γ with aging. However, we found a comparable 
hippocampal expression of PP1γ in aged versus young mice in our study 
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(unpublished data). Further to its expression, activity of PP1 can be regulated 
by >200 different proteins. These regulatory proteins target PP1 to different 
sub-cellular compartments, control its substrate specificity, as well as, bind to 
and block its phosphatase domains (reviewed in Munton et al. 2004). PP1 
inhibitor PP1R1A was decreased, whereas, PP1-nuclear scaffolding partner 
AKAP1 was increased with aging in the mouse hippocampus in our study. 
Altered expression of these PP1 regulators with aging explain, in part, 
increased nuclear PP1 activity with aging. However, increased nuclear PP1 
activity with aging likely implicates additional pathways. Off note, here is the 
evidence suggesting an altered balance between brain kinases and 
phosphatases with aging, leading to a dramatic increase in phosphatases 
(Norris et al. 1998). The molecular underpinnings of this aging-induced switch 
are not entirely clear, but may involve altered neuronal Calcium homeostasis 
(Toescu & Verkhratsky, 2000, Oh et al. 2013). Aging increases Calcium in 
neurons dually, through an increased Calcium influx across the plasma 
membrane, as well as, a reduced intracellular Calcium buffering (Oh et al. 
2013). Intracellular influx of Calcium may then activate PP1 through 
dephosphorylating its C-terminus (Hou et al. 2013). However, this hypothesis is 
purely speculative at this time and could benefit from more direct experimental 
evidence.  
 
Importantly, our in vivo data revealed a post-transcriptional blockade in the up 
regulation of miR-183/96/182 upon learning in aged mice, combined with an 
increase in nuclear PP1 activity in the mouse hippocampus with aging. To 
validate the hypothesis that aging-induced increase in nuclear PP1 activity 
impairs the microprocessor processing of miR-183/96/182, we took advantage 
of an in vitro model of neuronal aging. This model is based on the use of 
chemotherapeutic agent hydroxyurea (HU) to induce cellular senescence in 
neural stem cells  (Dong et al. 2014). We adapted HU to our in vitro model, and 
successfully induced cellular senescence in N2a cells, which was verified 
through an increased expression of senescent markers p21 and p53. 
Intriguingly, HU treatment impaired the microprocessor processing of pri-mir-
183/96, but not of pri-mir-182. This finding is in slight contrast to an equivocal 
effect of PP1 on both pri-mir-183/96 and pri-mir-182 processing. This peculiar 
regulation of pri-mir-182 processing on induction of cellular senescence could 
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be attributable to the recently revealed anomalous processing dynamics of the 
last member of miRNA clusters. The biogenesis of last member of miRNA 
clusters may involve an additional precursor form, ‘pro-miRNA’, under certain 
conditions (Du et al. 2015). Whether miR-182 biogenesis involves this 
additional precursor form, which may be regulated differently from the other 
members of the cluster, is an important question warranting further 
investigations.      
 
Virus-mediated hippocampal over-expression of miR-183/96/182 reversed 
ARCD in this study. Aged mice were stereotaxically injected in their 
hippocampus with a self-complementary adeno-associated viral vector 
expressing pre-mir-183/96/182. Over-expressing pre-mir-183/96/182 ensured 
that the impaired microprocessor-mediated biogenesis of pre-mir-183,-96, and 
-182 was countered, but a normally functioning Dicer was still required for the 
eventual effect. This strategy conclusively established that the association 
between miR-183/96/182 and ARCD specifically involves regulation of their 
microprocessor processing by nuclear PP1, and ARCD can be corrected if this 
step is bisected even in the presence of increased nuclear PP1.     
 
Up-stream inhibition of PP1 is another strategy to reverse ARCD, which is 
strongly supported by experimental evidence (Park et al. 2015). Environmental 
enrichment, an established memory-enhancing paradigm in aged rodents, 
decreased nuclear PP1 activity, and increased post-transcriptional biogenesis 
of miR-183/96/182 in our study. Besides this slow and persistent inhibition, 
rapid inhibition in the activity of nuclear PP1 with spaced learning also seems 
to transiently reverse ARCD. This is supported by the fact that aged rodents 
rarely show memory deficits when trained on the strong NOR protocol, which 
involves spaced learning, and is associated with inhibition of nuclear PP1 
(Pavloupolos et al. 2013). 
 
Taken together, these results highlight the potential of PP1- and miR-
183/96/182-based modalities to reverse ARCD and/or to delay dementia in the 
elderly. Indeed, learning and efficient LTM formation was enhanced in a cohort 
of elderly humans with early AD using a strategy of spaced retrieval learning, 
an extrapolated human equivalent of spaced learning in mice (Jang et al. 
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2015). Similarly, multi-modal stimulation, an extrapolated equivalent of 
environment enrichment, has shown promising results in reducing dementia 
symptoms in elderly humans with AD and minimal cognitive impairment 
(Luttenberger et al. 2012, Dannhauser et al. 2014). Finally, while miR-
183/96/182 based therapeutics seem infeasible for application in humans at 
this point, drugs selectively modulating their targets are available, and may 
make attractive candidates for treatment of ARCD. HDAC inhibitors have 
shown considerable promise in this regard (Gräff et al. 2013).      
 
4.4. Impaired PP1-dependent biogenesis of microRNA-183/96/182 
underlies cognitive dysfunction associated with TDP-43 proteinopathies 
Cognitive impairment is a hallmark feature of multiple neurodegenerative 
conditions, believed to be the result of neuronal death in the brain regions 
governing cognitive functions (Weintraub & Mesulam, 2009). While neuronal 
death provides a coherent mechanism for late deterioration of cognitive 
functions in neurodegenerative disorders, it does not explain the early 
progressive impairment of memory observed in these conditions. Such 
impairments often precede detectable neuronal death, and are rarely 
amenable to pharmacological interventions (Rapp et al. 2002, Ford et al. 
2015). Emerging evidence suggests that besides neuronal death, epigenetic 
mechanisms are responsible for early and persistent synaptic dysfunction and 
cognitive decline in the neurodegenerating brain (Gräff et al. 2012). These 
epigenetic changes include, notably, increased expression and activity of 
HDACs (Gräff et al. 2012, Stilling & Fischer, 2011). Our results suggest that 
impaired biogenesis of memory-promoting miRNAs could be an additional non-
genomic blockade of the cognitive functioning in neurodegenerating disorders. 
Notably, loss of TDP-43, a postulated etiology underlying neurodegenerative 
ALS/FTLD, impaired the microprocessor-mediated biogenesis miR-183/96/182. 
 
TDP-43 knockdown impaired the microprocessor processing of artificially 
introduced pri-mir-183 and pri-mir-182 in our in vitro microprocessor activity 
assays. Microprocessor activity can be controlled by TDP-43 through an 
increase in the stability of Drosha proteins in vitro (Di Carlo et al. 2013). 
Drosha/DGCR8 complex also interacts with TDP-43 in neuronal cell lines, 
where TDP-43 further binds to certain pri-mirs and differentially regulates their 
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processing by the microprocessor. These pri-mirs did not include pri-mir-183-
96-182 (Kawahara et al. 2012). Our study newly adds miR-183/96/182 to the 
list of miRNAs regulated by TDP-43, in a PP1-dependent manner.  Inhibition of 
PP1/PP2A by high-dose Okadaic treatment reversed the impairment in 
microprocessor processing of pri-mir-183/96 by PP1 knock down in our study. 
However, this impairment was not reversed when the cells were treated with 
low dose Okadaic acid, which only blocks PP2A (Ishihara et al. 1989). Taken 
together, these findings establish that TDP-43 regulates miR-183/96/182 
biogenesis at the level of the microprocessor complex, through a PP1-
mediated mechanism.  
 
Importantly, TDP-43 knockdown increased nuclear PP1 activity in N2a cells. 
This effect is not surprising, as TDP-43 also regulates the activity of PP2A, a 
phosphatase closely related to PP1 (Perera et al. 2014). Increases in PP1 and 
PP2A with TDP-43 knockdown could also reflect a homeostatic response to an 
increase in TDP-dependent cyclin-dependent kinases (Ayala et al. 2008). 
While the exact molecular underpinnings of nuclear PP1 increase on TDP-43 
knockdown remain elusive, they seem to involve mechanisms different from 
those observed in aging. Contrary to the observation in aged mice, analysis of 
human frontal cortex samples of ALS patients with TDP-43 pathology did not 
reveal alterations in the expression of PP1 regulatory sub-units. Instead, PP1γ 
was increased at the mRNA level. The increase in this predominantly nuclear 
PP1 isoform could reflect changes in the nuclear splicosomal machinery, of 
which TDP-43 is an integral component, in ALS/FTLD brains (Conti et al. 
2015). 
 
Mounting evidence suggests that miRNA regulation by TDP-43 is multi-
factorial, potentially affecting both the nuclear microprocessor, as well as, the 
cytoplasmic Dicer processing (Kawahara et al. 2012). While the regulation of 
the microprocessor by TDP-43 is specific to a sub-set of miRNAs, its control of 
Dicer seems more global. Disease-causing mutations in TDP-43 induce 
formation of stress granules, which interact with Dicer to inhibit its pre-miRNA 
processing activity (Emde et al. 2015). Thus, an effect of TDP-43 on Dicer 
activity could potentially confound our hypothesis about impaired 
microprocessor mediated biogenesis of miR-183/96/182 in TDP-43 
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proteinopathies. To exclude the contribution of Dicer, we quantified pre-mir-
183/96/182, as well as, a control precursor pre-mir-10b in both nuclear and 
cytoplasmic RNA fractions extracted from the brain samples of ALS/FTLD 
patients. ALS/FTLD patients with TDP-43 pathology had decreased pre-mir-
183/96/182, but an unperturbed pre-mir-10b in the nuclear RNA fraction. This 
result is in agreement with the hypothesis that TDP-43 loss of function in 
ALS/FTLD impairs the nuclear biogenesis of miR-183/96/182. On the other 
hand, both pre-mir-183/96/182 and pre-mir-10b were increased in the 
cytoplasmic fraction. Combined with a significant decrease of miR-183/96/182, 
and a non-significant decrease of miR-10b in ALS/FTLD brains, these results 
indicate a global impairment of Dicer-mediated miRNA biogenesis in TDP-43 
proteinopathies.              
 
Taken together, our results newly provide a novel mechanism for regulation of 
miRNA biogenesis by TDP-43 involving PP1, in addition to their previously 
known effects on Drosha and Dicer (Fig. 4.3). This effect is selective for miR-
183/96/182 and could be a potential mediator of cognitive dysfunction 
observed in TDP-43 proteinopathies. Whether or not, decreased miR-
183/96/182 contribute to the motoric phenotype of ALS is a question 
warranting further investigation. Although, there is evidence to suggest that 
miR-183 and miR-182 may have important roles in regulating muscular gene 
expression in animal models of pathological muscle atrophy (Kye et al. 2014, 
Hudson et al. 2014)    
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Fig. 4.3. Regulation of the microprocessor mediated miRNA biogenesis by TDP-
43. Nuclear TDP-43 is known to increase the microprocessor processing during 
neuronal differentiation by stabilizing Drosha (1). Further, pathological cytoplasmic 
accumulation of TDP-43 impairs Dicer processing through unclear mechanisms (2). 
Our data shows that TDP-43 can additionally regulate biogenesis of certain miRNAs 
by regulation the expression of PP1γ, predominantly nuclear isoform of PP1. TDP-43 
loss of nuclear function increases nuclear PP1 activity through increased mRNA 
expression of PP1γ, which impairs the microprocessor processing of miR-183/96/182 
(3).   
 
A decrease in miR-183/96/182 in ALS may also explain the unique 
neuropsychiatric phenotype associated with the disorder. ALS is associated 
with detectable cognitive impairment in around 50% of sporadic cases, which is 
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severe enough to be classified as dementia in roughly 15-20% cases (Ringholz 
et al. 2005). However, the prevalence of depressive symptoms in ALS patients 
is surprisingly low (<20%) in comparison to other neurodegenerative conditions 
(40-50%) (Rabkin et al. 2005). A report from another research groups 
suggested that miR-183/96/182 over-expression in mouse hippocampus 
promotes pro-depressive behavior in mice (Li et al. 2015). This contrasting 
effect of miR-183/96/183 on LTM formation versus behavior could provide a 
plausible explanation for decreased rate of depression in ALS patients, despite 
an increase in cognitive deficits and considerable physical disability.  
 
Further, decreased miR-183/96/182 and their possible regulation by PP1 could 
explain the distinct disease-modifying effect of diabetes mellitus type 2 (DM2) 
on motor versus cognitive symptoms of ALS. While pre-morbid DM2 delays the 
onset of motor symptoms in ALS patients, it worsens their cognitive functioning 
(Jawaid et al. 2010). Notably, DM2 is associated with an increased PP1 activity 
in the skeletal muscles (Rastogi et al. 2003). A similar increase in PP1 activity 
in the brain with DM2 could lead to further suppression of miR-183/96/182 in 
ALS brains leading to worse cognitive functions, despite the beneficial effects 
of DM2 on the motor functions (Jawaid et al. 2010, Jawaid et al. 2013, Jawaid 
et al. 2015).         
 
The results of this study highlight the potential of miR-183/96/182 and PP1-
based therapeutics in treating CD TDP, similar to their effect on ARCD. 
However, the dual effect of TDP-43 on microprocessor, as well as, Dicer 
processing might require slight modifications to the miR-183/96/182 over-
expression strategy we used for reversing ARCD. A viral vector expressing 
mature miR-183/96/182 or their mimics, thus bisecting the requirement of a 
functional Dicer, is more likely to have a cognitive enhancing effect for CD 
TDP. 
 
4.5. General relevance of the results  
The findings of this thesis are highly momentous broadly to the scientific field, 
as they not only substantially advance our understanding of the molecular 
mechanisms governing memory, but also newly identify a molecular pathway 
relevant to ARCD and cognitive dysfunction associated with TDP-43 
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dysfunction. miR-183/96/182 and their modes of regulation should also be 
investigated in other cognitive functions, especially mnemonic processes like 
social cognition and decision-making. In human, these functions are essential 
to most aspects of an active life, and are altered in many neuropsychiatric 
diseases.  
 
Further, an important future development could concern investigating the role 
miR-183/96/182 might play in mediating the effects of environmental factors, 
which increase the risk of dementia, such as brain injury, traumatic stress etc. 
(Qureshi et al. 2010, Gardner et al. 2014). By extension, the contribution of 
miR-183/96/182 to the protective effects of favorable factors such as exercise 
and higher education on dementia risk would also be important to examine 
(Satizabal et al. 2016).  
 
Finally, the identification of molecular steps through which PP1 regulates miR-
183/96/182 maturation may help better understand other pathological 
conditions that involve aberrant microRNA processing, for example cancer, 
neurodegenerative disorders, cardiovascular malformations, and obesity (Li & 
Kowdley, 2012). Importantly in this respect, miR-183/96/182 has been 
associated with several forms of cancer in humans (Dambal et al. 2015). Using 
the regulation of miR-183/96/182 by PP1 as a prototype model to study how 
miRNA biogenesis is dysregulated in disease conditions may have wide-
ranging implications for human health.     
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